QuantumScape Corporation (NASDAQ: QS) — A $2.4 Billion Option on a Licence Volkswagen Prices at $130 Million

An independent equity research note. Report date: 2026-07-31 | Price reference: $5.23 (2026-07-30 close) | Shares outstanding: 619.1m (587.1m Class A + 32.0m Class B) Market capitalisation: ~$3.24bn | Enterprise value (hand-built): ~$2.41bn | Liquidity: $859.0m | Revenue: $0 Sector: Consumer Discretionary — Auto Parts & Equipment (development-stage solid-state battery technology) Primary filings: FY2025 10-K (qs-20251231, filed 2026-02-25); Q2 2026 10-Q (qs-20260630, filed 2026-07-24); DEF 14A filed 2026-04-23. CIK 0001811414. Coverage status: Initiation.

Sections 1–15 of this article carry no investment recommendation and no price target; they discuss valuation solely as embedded expectations and scenarios. The single, deliberate exception is the Claude's Take block immediately below, which is clearly labelled as the author’s own subjective opinion. This article is general information, not investment advice.

⚡ Claude’s Take

The author’s own independent, subjective opinion — general information only, not investment advice, and not a recommendation to buy or sell any security. The analytical body of this article (sections 1–15 below) takes no position and carries no price target.

AVOID at $5.23 — and do not short it. “The best science project on the Nasdaq, priced as a business.”

The call. AVOID, but not a short. QuantumScape has the most credible solid-state battery technology in the Western listed universe and a genuinely unencumbered balance sheet — $859.0m of cash and securities, $30.1m of finance leases, and no other debt of any kind. That is real, and it is why this is not a short. But the price is wrong, and the reason it is wrong is a single comparison that sits in plain sight in the 10-K and appears in no sell-side note I can find. Volkswagen — a 27.3% shareholder, a partner since 2012, with two designated board seats and by far the deepest technical diligence of any party on earth — has agreed to pre-pay $130 million for a licence covering up to 85 GWh a year of QuantumScape’s flagship automotive technology. The public market is paying roughly $2.41 billion of enterprise value for the same asset. The best-informed counterparty in the world prices the flagship licence at about 5% of what the equity market prices the company at. That gap is the report.

The gap widened in July. On 2026-07-16 PowerCo cut its maximum funding commitment for the joint scale-up programme from $130.7 million to $75.4 million — a 42% reduction, and “inclusive of amounts paid to date” — while replacing cost reimbursement with milestone payments. The company disclosed the number in an 8-K and in a subsequent-events note; the shareholder letter published the same day described it only as “an amended set of milestones and payments” and gave no figure. Meanwhile the metric management substituted for a cash-runway update — “customer billings,” $10.8m in Q2 — is on the company’s own auditors’ analysis largely not a sale at all: $10.4m of it was booked as a capital contribution to additional paid-in capital from a related party under ASC 730-20 and appears in financing cash flow. The headline commercial-traction number is closer to an equity injection from Volkswagen than to revenue.

What the market is pricing correctly, and what it is not. Correctly: the technology is scarce, the cash is real, cost discipline has genuinely improved (opex −13% year on year, capex guidance cut twice to $27–37m), and a 3.7-year runway means there is no forced-financing catalyst. Incorrectly: the shape of the distribution. At $5.23 the stock sits at the top of my bull case, not in the middle of the range. My scenarios land at roughly $0.97–$1.62 (bear), $1.94–$2.91 (base), $3.23–$6.46 (bull) per share. You are paying close to the successful outcome for an agreement that has not been signed — the 10-K says the parties “intend to enter into” the IP Licence, subject to milestones — in an industry where the incumbent technology it must displace is getting 3–8% cheaper every year (BNEF: $108/kWh packs in 2025, $105/kWh forecast for 2026, LFP packs at $50/kWh) and where Toyota, Samsung SDI and CATL are all targeting the same 2027–2030 window. The zone where I would be paid to wait rather than pre-paying is roughly $2.00–$3.00 — about 1.4–2.2x liquidity, versus 3.8x today.

The framing: a quantified falling knife, not a value name. Say it precisely, because the tape says it precisely. The 50-day EMA has been below the 200-day for 110 consecutive sessions since 2026-02-23; price is 22% below the 200-day after 38 straight closes beneath it. Every horizon from three months to five years carries a negative Sharpe ratio (y5 −0.32 on 86% volatility with a 91% max drawdown). In the factor model, momentum is zeroed in all four nested models, quality is zeroed, and the value loading decays to nothing once sector is stripped; what remains is LowVolatility −1.57, Market +1.51, SmallSize +1.43 and Clean Energy +0.61. Its single closest factor sibling is a clean-energy ETF. This is a maximum-volatility beta expression of a deflating theme, with 75% annualised idiosyncratic volatility — which is why one headline moves it 15–35% in a session and why shorting it is a good way to be right and still lose.

One more datum, and it is the one I weight most. I parsed all 428 Form 4 filings of the last five years. There is not a single open-market purchase by any officer or director — none, ever, through a fall from $132.73 to $5.23 — against $368.5 million of insider sales at a weighted-average price of $12.45, including a $42.3 million cluster in the five weeks around the October 2025 high in which the CEO, CFO, CTO, Chief Legal Officer, both founder-directors and three other directors all sold. Selling is ambiguous and mostly diversification. Never buying is not. The people who know whether the separator works have had six years and a 96% drawdown in which to say so with their own money, and have said nothing.

Conviction: medium. Tag: “the best science project on the Nasdaq.” Flips bullish if PowerCo actually executes the IP Licence Agreement and pays the $130m initial royalty — that single event converts “intends to enter into” into a contract and validates sixteen years of work — and a second, non-Volkswagen OEM signs a licence rather than a research agreement. Flips bearish if PowerCo declines to sign or further narrows the programme, or if QuantumScape files a new S-3 shelf and restarts an at-the-market programme below $6 — it is a well-known seasoned issuer, so an automatically effective shelf is one filing away, and the fact that it has not filed one since its last shelf expired on 2025-08-10 tells you management does not want to sell stock at this price either.

📈 Stock Price Action — Five-Year Event Map

QuantumScape is one of the great round trips of the de-SPAC era. From a $9.90 first close in August 2020 it reached an all-time intraday high of $132.73 on 2020-12-22 — briefly a larger market capitalisation than Ford — before falling 96.1% to $5.23 today. It bottomed at an all-time intraday low of $3.40 on 2025-04-08, then rallied 461% to $19.07 on 2025-10-15, and has since given back 72.6%. The 52-week range is $4.77–$19.07; the stock is down 49.8% year to date. There have been no dividends and no splits, so adjusted and unadjusted prices are identical and none of the moves below are ex-dividend artefacts.

Cycle narrative. (1) The 2020 melt-up was a pure narrative event: the merger announcement, a 12-month lock-up that kept float scarce, and a December “Battery Day” that produced single-layer cell data — the stock rose 1,240% in four months on zero revenue and no product. (2) The unwind began the moment supply arrived: 2021-01-04 alone was −40.8% on lock-up expiry, and the subsequent two years erased 96% of the peak as rates rose and every pre-revenue de-SPAC de-rated. (3) The January 2024 spike is the most analytically interesting move in the whole series, because it is the one time an external party validated the technology: PowerCo’s own laboratories confirmed the A-sample cell exceeded the 700-cycle / 20%-capacity-loss industry standard for that development phase, delivering >1,000 cycles at >95% retention on a 24-layer cell. (4) The July 2024 Collaboration Agreement converted QuantumScape from a would-be manufacturer into a would-be licensor — the “capital-light” pivot that defines the current business model. (5) The 2025 rally was driven by process and supply-chain news rather than customers: the Cobra separator process (claimed 25x faster heat treatment), a Ducati motorcycle demonstration staged with Volkswagen, and co-development agreements with Corning and Murata — the stock nearly sextupled without a single dollar of revenue appearing. (6–8) The 2026 unwind is the mirror image. Demand-side reality reasserted itself (US BEV share fell to 6% in H1 2026 from 7%), the Honda agreement produced a 17% one-day pop but no 8-K and no economics, and the July print revealed that the anchor customer had quietly cut its maximum commitment by 42%. Price moves are Fact; the attributed drivers are Interpretation.

1. Executive Summary

QuantumScape Corporation is a sixteen-year-old, development-stage company attempting to commercialise an anode-free, solid-state lithium-metal battery cell. It was founded in 2010, went public through a SPAC merger in November 2020, and as of 30 June 2026 had never recorded a dollar of revenue. Its own 10-Q states the position plainly: “Planned principal operations have not yet commenced.” Cumulative operating losses since 2020 total $2.41 billion; cumulative free cash outflow is $1.79 billion; the accumulated deficit stands at $3.99 billion against $5.04 billion of paid-in capital.

The business model changed fundamentally in July 2024. Rather than build gigafactories, QuantumScape now intends to license its technology, principally to PowerCo SE, the battery subsidiary of Volkswagen Group — which is simultaneously its largest shareholder (27.3% of the vote), the designator of two board seats, and its only meaningful funding partner. The contemplated PowerCo IP Licence Agreement, not yet signed, would grant a non-exclusive, perpetual, royalty-bearing licence covering up to 85 GWh of annual production, against a $130 million pre-paid initial royalty subject to a diminishing clawback.

Three findings dominate this initiation.

First, the anchor relationship is contracting, not expanding. On 2026-07-16 PowerCo cut the maximum it will contribute to the joint scale-up programme from $130.7 million to $75.4 million — inclusive of amounts already paid — and replaced cost reimbursement with milestone-gated payments. This was disclosed in an 8-K and a subsequent-events note but given no dollar figure in the shareholder letter published the same day.

Second, the headline commercial metric is not commerce. “Customer billings” ($19.5m FY2025, $11.0m Q1 2026, $10.8m Q2 2026) is defined by management as invoices issued “regardless of accounting treatment” and is “not a substitute for revenue under U.S. GAAP.” It appears on no line of any financial statement; there is not even a receivables line to trace it to. The identifiable majority of it — $10.4m in Q2 2026 — was recorded as a capital contribution to additional paid-in capital from a related party under ASC 730-20 and flows through financing activities.

Third, the valuation already discounts success. Enterprise value of ~$2.41bn compares with the $130 million the world’s most informed counterparty agreed to pre-pay for the flagship licence, and with a maximum contracted licensed volume (85 GWh) that, at a plausible $2.50/kWh royalty and 100% utilisation, would generate ~$213m a year — less than half QuantumScape’s current $430m annual operating cost base.

Against this: the balance sheet is genuinely strong and essentially unlevered ($859.0m of liquidity, $30.1m of finance leases, no borrowings, no converts, no preferred); cost discipline is real (opex −13% year on year, capex guidance cut twice, a 12% reduction in force, ~142,000 sq ft of space shed); the technology is scarce and has been externally validated once, by PowerCo’s own laboratories; and the runway extends roughly 3.7 years, to about mid-2030. There is no near-term financing cliff.

The competitive-advantage verdict is negative. There is no demonstrable moat because there are no financial outcomes to demonstrate one with. The only candidate — intangibles — is being contractually diluted: QuantumScape intends to grant a perpetual licence to its largest shareholder, and its own risk factors disclose that jointly-owned foreground intellectual property on the ceramic separator may be used, licensed and improved by partners “without requiring our approval.” The industry is structurally hostile: lithium-ion pack prices are deflating 3–8% a year toward $50/kWh for LFP, the US EV market is contracting, and every credible solid-state competitor is targeting the same commercialisation window.

No recommendation and no price target appears in this section or anywhere in the analytical body of this article.

2. Business Overview

2.1 What the company actually is

QuantumScape Corporation is the public holding company for QuantumScape Battery, Inc. (“Legacy QuantumScape”), founded in 2010 by Jagdeep Singh, Dr. Timothy Holme and Prof. Dr. Fritz Prinz of Stanford. The public entity was created in November 2020 when Legacy QuantumScape merged with Kensington Capital Acquisition Corp., a special-purpose acquisition company. It is headquartered at 1730 Technology Drive, San Jose, California, and employed approximately 700 people at 2025 year-end, following a 12% reduction in force executed during 2025 “to align our work force with our capital-light licensing focus.”

The company operates in one segment. It has no products for sale, no customers in the GAAP sense, no backlog, no inventory line on its balance sheet, and no revenue. Its 10-Q describes it as “a development-stage company with no revenue to date.”

2.2 The technology

The technical proposition is specific and, unusually for a story stock, falsifiable. Conventional lithium-ion cells store lithium in a host anode — graphite, or graphite blended with silicon. Hosting lithium in a foreign material costs energy density, adds cost, limits power, and (in the case of silicon) creates cycle-life problems from repeated expansion and contraction.

QuantumScape’s architecture eliminates the anode entirely. As manufactured, a QS cell has no anode. The lithium-metal anode plates in situ during the first charge, drawn from lithium already present in the cathode material. If it works, this removes an entire bill-of-materials line and its associated manufacturing steps, and it also shortens the formation-and-aging step that is one of the most capital-intensive parts of conventional cell manufacturing.

The enabling component — and the whole company — is a proprietary solid-state ceramic separator: a dense, entirely inorganic film thinner than a human hair, claimed to be chemically stable in direct contact with lithium metal (one of the most reactive elements in the periodic table) and to resist dendrite formation at automotive current densities and room temperature. QuantumScape states its separator “uses the only material we know of” that can do this. It is flexible because it has a low defect density; it is cut into pieces and assembled into unit cells consisting of a double-sided cathode with a separator and anode current collector on either side, which are stacked into multilayer cells.

The first targeted commercial product is the QSE-5, a roughly 5 amp-hour cell in a hybrid pouch/prismatic format designed to accommodate the expansion and contraction of the plating lithium. Published specifications are >800 Wh/L energy density (with “up to 850 Wh/L” claimed for larger formats) and <15-minute 10%-to-80% fast charge. Current-generation cells pair the solid separator with an organic liquid catholyte on the cathode side — a point worth noting, since “solid-state” here means a solid separator, not a fully solid cell; solid catholytes remain “part of our ongoing research and development investigations.”

Two named manufacturing processes matter. Cobra is the proprietary higher-throughput separator production process, integrated into baseline cell production in 2025 and now demonstrated on larger-area separators. The Eagle Line is the highly automated pilot production line in San Jose, installed in 2025 and inaugurated in February 2026. Per the Q2 2026 letter, core Eagle Line tools are running above 90% uptime and the company aims to “further double cell output in the second half of 2026.”

2.3 How the company intends to make money

This is the pivot that defines the current investment case, and it happened on 2024-07-05.

Until 2024 QuantumScape’s implicit plan was to manufacture. It was building toward its own capacity; capex peaked at $158.8m in 2022. Since the Collaboration Agreement with PowerCo, the model is capital-light licensing: QuantumScape develops the technology and the process, transfers it to partners, and collects royalties on cells that partners manufacture and sell.

The commercial architecture, as disclosed:

• The Collaboration Agreement (July 2024, amended and restated July 2025, amended again July 2026) governs the joint scale-up team working at the San Jose pilot line, funded by PowerCo contributions. Maximum PowerCo contribution: originally “up to $130.7 million… over the next two years”; as amended on 2026-07-16, a maximum of $75.4 million inclusive of amounts paid to date, now milestone-gated rather than cost-reimbursed.
• The PowerCo IP Licence Agreement is the prize, and it does not yet exist. The parties “intend to enter into” it, “subject to the completion of certain milestones.” If signed, it would grant PowerCo a non-exclusive, limited, royalty-bearing, perpetual licence to manufacture and sell QSE-5-based batteries primarily for automotive applications, “initially at one or more PowerCo facilities that together have an annual capacity of up to 40 GWh, expandable by an additional 40 GWh,” plus (per the 2025 amendment) up to a further 5 GWh including for non-Volkswagen customers — a contracted maximum of 85 GWh annually. PowerCo would pre-pay an initial royalty fee of $130 million, credited against future royalties, subject to a time-based diminishing clawback if PowerCo terminates early.
• Other automotive relationships are development agreements, not licences. Management states it works with “four Top-10 OEM customers” including Honda, under “customer sampling, technology evaluation and joint research and development agreements.” The Honda R&D joint research agreement announced 2026-06-18 is explicitly a research agreement; no supply or licence economics have been disclosed, and no Item 1.01 8-K was filed for it.
• Ecosystem partners Murata Manufacturing and Corning Incorporated are working with QuantumScape toward high-volume ceramic separator production using the Cobra process. Neither has disclosed economics.
• New verticals, announced in the Q2 2026 letter: QSEV (electric vehicles), QSDC (AI data centres) and QSAS (aerospace and defence). QSAS “recently has shipped QSE-5 cells to a major American defense prime.” QSDC is “engaged with original design manufacturers (ODMs).” Both are at the earliest stage of customer engagement, and the company’s own forward-looking-statement disclosure concedes that these markets “remain at an early stage of customer engagement, with no assurance that customer interest will convert to development agreements, purchase commitments, or revenue.”

2.4 Revenue segmentation, recurring revenue, customer mix

There is none of any of these. Revenue is zero; segmentation is not applicable; recurring versus non-recurring is not applicable. The only cash inflows from third parties are (a) the PowerCo programme contributions, accounted for as equity, and (b) whatever sits behind the residual “customer billings” from ecosystem partners and other OEMs, which the filings do not locate in the financial statements.

Verdict: A sixteen-year-old research organisation with one deep, conflicted anchor relationship, an unsigned flagship licence, a genuine and scarce technical asset, and no commercial revenue. The 2024 pivot to licensing was strategically correct — QuantumScape could never have funded gigafactories — but it converts the company into a pure royalty option whose value depends entirely on counterparties it does not control and whose negotiating leverage it structurally lacks.

3. Industry Dynamics

3.1 The industry QuantumScape is trying to enter

Lithium-ion cell manufacturing is a scale-commodity business with the structural characteristics investors should least want to see: enormous fixed capital intensity, a Chinese cost base that Western producers cannot match, ferocious price deflation, buyers (auto OEMs) who are among the most powerful and most cost-focused purchasers in any industry, and a product that is increasingly specified on cost per kilowatt-hour rather than on performance.

The defining fact is deflation. BloombergNEF’s December 2025 survey put the global average lithium-ion pack price at $108/kWh, down 8% year on year and a record low, with a 2026 forecast of a further ~3% decline to $105/kWh. Regional dispersion is severe: China averaged $84/kWh, while North America and Europe ran 44% and 56% higher. Lithium iron phosphate — the chemistry that has taken share fastest — consistently records the lowest prices in the survey at $36/kWh at the cell level and $50/kWh at the pack level. BNEF attributes the decline to a glut of Chinese manufacturing capacity, intensifying competition, and the ongoing shift toward LFP.

This is the single most important industry fact for QuantumScape, and it cuts hard against the thesis. The incumbent technology QuantumScape must displace gets 3–8% cheaper every year while QuantumScape remains pre-production. When QuantumScape de-SPAC’d in late 2020, pack prices were roughly $140–150/kWh and the promise of a premium-priced, differentiated cell had a wide price umbrella beneath it. A technology targeting volume production in 2028–2030 must instead compete against something approaching a $50/kWh LFP pack. Every year of delay compresses the ceiling on what a solid-state cell can charge and, by extension, on what royalty a licensor can extract.

3.2 Competitive intensity in solid-state specifically

The 2020 narrative — that QuantumScape had a multi-year lead in an empty field — no longer holds. The field is crowded, well-capitalised and converging on the same window:

The industry consensus, per IDTechEx and Interact Analysis, is: pilot lines mid-2020s, early commercialisation 2027–2028, mainstream mass production clustered around 2030 and later. QuantumScape’s realistic window sits inside that band, not ahead of it. The first-mover premium embedded in the 2020–2021 equity price has been competed away.

Two observations sharpen this. First, Toyota, Samsung SDI and CATL are all vertically integrated manufacturers. If any of them succeeds, it captures the entire economics of the cell. QuantumScape, having chosen to license, captures a royalty — a small slice of a product it does not make, from a customer that could in principle develop around it. Second, BMW already has a solid-state test vehicle on public roads running Solid Power cells. QuantumScape’s most prominent demonstration to date is a Ducati V21L electric racing motorcycle, staged jointly with Volkswagen — its own related party — at IAA Mobility in September 2025.

3.3 The demand side has deteriorated

The end market against which QuantumScape was underwritten is shrinking in its home geography. Per the U.S. Energy Information Administration, battery-electric vehicles fell to 6% of new US light-duty sales in the first half of 2026, down from 7% a year earlier, following the expiry of the federal EV tax credit in September 2025. BEV share had spiked to a record 12% in September 2025 — the month immediately before expiry — which makes the subsequent collapse a pull-forward as much as a decline. Hybrids reached a record 16% share in Q2 2026. Most damaging for QuantumScape specifically: the luxury segment, the only plausible first home for a premium-priced solid-state cell, saw BEV share fall from 22% to 14% year on year.

A premium cell needs a premium vehicle to live in. That is precisely the segment retreating fastest.

3.4 The capital cycle

Applying the capital-cycle lens of Marathon Asset Management (Edward Chancellor, Capital Returns): the battery industry is squarely in the post-boom oversupply phase of a capital cycle. Vast capacity was committed in 2021–2023 against demand forecasts that have since been cut repeatedly. The consequences are textbook — falling prices, delayed and cancelled gigafactories, consolidation, and returns migrating to the lowest-cost incumbent with the highest asset utilisation.

This matters enormously for timing. In the expansion phase of a capital cycle, a differentiated new entrant can command scarcity rents. In the digestion phase, capital is abundant, incumbents are desperate for volume, and the marginal buyer of new technology is price-sensitive and cash-constrained. QuantumScape is arriving with a premium product into an oversupplied market. That is the worst possible entry timing, and it is a direct consequence of a decade of technical delay rather than of any strategic error.

Verdict: STRUCTURALLY UNATTRACTIVE, AND DETERIORATING. Batteries are a deflating scale-commodity business in the digestion phase of a capital cycle, dominated by Chinese incumbents, sold to the world’s most powerful buyers, where every credible competitor targets the same window, and where the specific end market QuantumScape needs — premium Western EVs — is contracting. A moat in this industry would need to be extraordinary to produce excess returns. QuantumScape’s is not yet demonstrable at all.

4. Competitive Position

4.1 Applying the framework honestly

Under Greenwald’s Competition Demystified, the only competitive advantages that matter are barriers to entry, and they come in three genuine forms: supply-side cost advantages, demand-side customer captivity, and economies of scale combined with captivity. The empirical tests are market-share stability and ROIC persistently above the cost of capital.

QuantumScape has no market share, no customers, no revenue and no ROIC. Neither test can be run. This is not a rhetorical point — it is the analytical core of this section. A company sixteen years old and six years public that cannot be subjected to either of Greenwald’s tests has, by definition, not yet demonstrated a competitive advantage. Anything said about its moat is a forecast, not a finding.

What can be assessed is whether a prospective barrier to entry exists, and if so, whether QuantumScape’s own conduct is preserving or eroding it.

4.2 The candidate: intangibles

The only plausible moat category is intangibles — patents plus process know-how.

The patent estate: “more than 400 U.S. and foreign patents and patent applications” owned or exclusively licensed as of 2025-12-31, “including broad fundamental patents around our core technology.” Note the disclosure combines granted patents and pending applications into one figure and does not split them, which is a meaningful ambiguity — an application is not a right.

The know-how is arguably the stronger asset. The separator composition took, on the company’s own account, “over ten years to develop,” and manufacturing a defect-free, ultra-thin, dense inorganic ceramic film at automotive volumes is a genuinely hard materials-processing problem. The Cobra process, and the pilot-line experience embedded in the Eagle Line, represent real accumulated capability that a competitor could not replicate quickly.

And there is one piece of genuine external validation, which deserves proper weight because it is the only one: in January 2024 PowerCo’s own laboratories confirmed that a 24-layer QuantumScape A-sample cell completed more than 1,000 charge cycles retaining more than 95% of capacity, against an industry-standard target for that development phase of 700 cycles and up to 20% capacity loss, while also meeting fast-charge, safety and self-discharge criteria. That is not a company press release; that is a customer’s laboratory certifying results. It is the single strongest fact in the bull case.

4.3 Why the intangible does not currently constitute a moat

Three disclosures in QuantumScape’s own 10-K, read together, substantially undermine the intangible barrier. They are quoted rather than paraphrased because their precision matters.

(a) The flagship licence is non-exclusive and perpetual. From the FY2025 10-K, Item 1A: “Under the PowerCo IP License Agreement, if entered into, we intend to grant PowerCo a perpetual license to some of our intellectual property. This license may limit our ability to prohibit third parties, including PowerCo and its sublicensees, from exploiting our licensed intellectual property in perpetuity.” An intangible asset granted away permanently, non-exclusively, with sublicensing rights, to the counterparty best placed to displace you, is a depreciating asset — not a barrier.

(b) The foreground IP on the separator is jointly owned and freely exploitable by partners. Also Item 1A: “We have entered into joint development agreements with various business partners, for example, for the development and commercialization of our ceramic separator, that involve joint ownership of foreground intellectual property. These agreements may allow our partners to independently use, license, or develop improvements to or derivatives of jointly owned intellectual property without requiring our approval, or restrict our use of such jointly owned intellectual property.” The ceramic separator is not merely a component — it is the entire technical basis of the company. QuantumScape is disclosing that improvements to its crown jewel may be owned and commercialised by partners without its consent.

© The partners with that access are the most capable process manufacturers on earth. Volkswagen and PowerCo, Murata Manufacturing (the world’s leading multilayer-ceramic-capacitor maker — thin dense ceramic films at extreme volume are precisely its core competence) and Corning Incorporated (glass and ceramic process engineering at scale). These are exactly the organisations that could, over a decade, internalise the process knowledge QuantumScape is transferring to them.

4.4 The other moat categories, briefly

• Switching costs: none. There is no installed base to switch from.
• Network effects: none, and none is plausible for a cell chemistry. Any claim to the contrary should be rejected.
• Cost advantage: the anode-free architecture may eventually produce a bill-of-materials advantage — the 10-K says eliminating the anode “could result in a meaningful cost of goods sold advantage once sufficient scale and process maturity are achieved.” Neither condition is met, and the company has never published a cost-per-kWh figure.
• Economies of scale: none. There is no scale. Under the licensing model, any scale economies accrue to the licensee, not to QuantumScape.
• Brand: irrelevant. Automotive OEMs qualify on specification and cost.

4.5 Direct comparison with named competitors

Against Toyota, Samsung SDI and CATL, QuantumScape’s disadvantage is structural rather than technical: they are integrated manufacturers who capture the full cell economics; QuantumScape has chosen to capture a royalty. If solid-state works, the integrated players capture roughly 100% of the value created; QuantumScape captures a low-single-digit percentage.

Against Solid Power, the comparison is uncomfortable in a different way. Solid Power recognised $21.7m of GAAP revenue in FY2025 and $3.1m of revenue and grant income in Q1 2026, has BMW running an i7 test vehicle on its cells, is installing a pilot line at SK On, and guides to only $85–100m of 2026 cash investment — under half QuantumScape’s burn — while carrying $435.3m of liquidity. Solid Power’s market capitalisation is approximately $450m, roughly 1.0x its liquidity. QuantumScape’s is $3.24bn, 3.8x its liquidity. QuantumScape’s technology may well be better. But the market is ascribing ~$2.4bn to QuantumScape’s intangibles and roughly $15m to Solid Power’s.

Against SES AI, the lesson is a cautionary one: a lithium-metal peer with a similar de-SPAC vintage has abandoned EV cells altogether, redirecting to AI materials discovery, drones and stationary storage, and now guides to $30–35m of FY2026 revenue. That is what capitulation looks like in this cohort, and it happened this year.

Verdict: NO DEMONSTRABLE MOAT — a scarce technical asset that the company is contractually diluting. QuantumScape possesses genuine, hard-won, externally-validated technology that would take a competitor years to replicate. It does not possess a competitive advantage in any sense that produces returns, because (i) no financial outcome exists that would deteriorate without it — the operative test for any moat claim; (ii) the flagship commercialisation vehicle is a perpetual non-exclusive licence to its largest shareholder; and (iii) the foreground IP on the core component is jointly owned and exploitable by partners without QuantumScape’s approval. This is a differentiated product without a barrier to entry — historically, a business that earns its cost of capital at best.

5. Growth History and Forward Opportunities

5.1 Growth history: there is none to report

QuantumScape has no revenue history, no customer count, no unit volumes, no backlog and no bookings. The only “growth” series available are cost series, and they run the wrong way for six years before beginning to reverse:

The only meaningful operational progression is a milestone ladder, which is worth setting out because it is the actual product of $2.4bn of spending:

• 2022 — first A0 prototype cells shipped to multiple OEMs for testing.
• Jan 2024 — PowerCo laboratories confirm A-sample cell exceeds industry-standard endurance (>1,000 cycles, >95% capacity retention, 24 layers).
• 2024 — low-volume production of first B-sample QSE-5 cells begins; shipped for automotive customer testing.
• 2025 — Cobra separator process baselined and integrated into cell production; B1 samples shipped (announced October 2025); Eagle Line installed; first public technology demonstration (Ducati V21L) with Volkswagen/PowerCo at IAA Mobility.
• Feb 2026 — Eagle Line inaugurated; initial ramp begins.
• H1 2026 — core Eagle Line tools above 90% uptime; larger-area Cobra separators demonstrated; QSE-5 cells shipped to “an additional automotive OEM customer” and to “a major American defense prime.”

Read charitably, that is steady, verifiable technical progress on a hard problem. Read sceptically, it is the automotive qualification ladder’s A → B stage after sixteen years — with C samples, production validation, and serial production still ahead, and the 10-Q’s own language conceding that “the timelines for each stage involve uncertainty.”

5.2 The forward opportunities

Automotive (QSEV). The base case. Four “Top-10” OEM relationships, of which one — PowerCo — has a contractual pathway to a licence and three are development or research agreements. The contracted ceiling is 85 GWh at PowerCo. For context, that is real but not transformational: it is roughly the annual output of a single large modern cell maker, and it is a maximum, not a commitment.

AI data centres (QSDC). The newest and most fashionable pillar, announced in Q2 2026 and led by a new hire from MediaTek/Broadcom/Micron. The logic is coherent: as AI rack power approaches the megawatt threshold, 800V DC architectures borrowed from automotive need energy storage with high power density and a superior safety profile. QuantumScape is “engaged with ODMs.” There is no disclosed customer, no disclosed economics, and no product designed for the application.

Aerospace and defence (QSAS). The most strategically interesting, and the one with a real structural argument behind it. Conventional lithium-ion depends on graphite anode material “almost exclusively sourced from China”; an anode-free architecture eliminates that dependency entirely. For a defence customer, supply-chain sovereignty can outweigh cost — which is exactly the condition under which a premium cell can earn a premium price. The board appointment of Dr. Ross Niebergall (ex-President of L3Harris’s Aerojet Rocketdyne segment, ex-CTO of L3Harris and Harris) in March 2026 preceded the vertical’s announcement and signals genuine intent. QSAS “recently has shipped QSE-5 cells to a major American defense prime.”

Larger-format cells. Customer interest in formats larger than the 5 Ah QSE-5 has been demonstrated on Cobra, which improves packaging efficiency and therefore pack-level energy density. This is incremental and credible.

5.3 The honest assessment of the new verticals

The defence and data-centre pivots are, in my reading, simultaneously the most economically rational thing management has done and a tell about the automotive base case.

Rational, because the economics genuinely are better. Defence and data-centre customers pay for performance and supply-chain security rather than for $/kWh; volumes are smaller, which suits a company that will never have gigafactory scale; and qualification timelines can be shorter than the seven-to-ten-year automotive cycle. If QuantumScape has a path to real revenue before 2030, it more likely runs through QSAS than through QSEV.

A tell, because the timing is not coincidental. The verticals were announced in the same quarter in which the anchor automotive customer cut its funding commitment by 42%. Broadening the addressable market is what a company does when its core market narrows. The company’s own forward-looking-statement disclosure is unusually candid on the point: these markets “remain at an early stage of customer engagement, with no assurance that customer interest will convert to development agreements, purchase commitments, or revenue.”

Verdict: NO GROWTH TO ASSESS; THE FORWARD OPPORTUNITY IS REAL BUT ENTIRELY UNPRICED IN CONTRACTS. Sixteen years and $2.4bn of cumulative operating loss have produced verifiable technical progress from A-samples to B1-samples, one external validation, and zero revenue. The three-vertical expansion is strategically sensible and the defence angle has a genuine structural rationale, but not one dollar of it is contracted. The quality of this “growth” cannot be assessed because none of it exists yet.

6. Financial Quality

6.1 The income statement

There is no revenue line. There is no gross margin. There is no operating leverage to measure. What exists is a cost base and an interest-income stream from the cash pile.

Q2 2026: total operating expenses $106.1m (R&D $82.5m, G&A $23.6m); loss from operations $(106.1)m; interest income $8.4m against $0.5m of interest expense; net loss $(98.2)m, or $(0.16) per share on 617.1m weighted shares. H1 2026: opex $215.3m, net loss $(199.0)m, $(0.32) per share.

The reported year-on-year improvement deserves scrutiny, and this is the most important quality-of-earnings point on the income statement. R&D fell $18.6m (−18%) in Q2 2026. Management’s own MD&A attributes it to: a $13.6m decrease in impairment loss, a $5.6m decrease in depreciation and amortisation, and a $2.1m decrease in facility costs — partly offset by increases of $1.3m in materials and $0.9m in stock-based compensation. In other words, essentially the entire reported decline in research spending is the absence of last year’s asset write-offs plus lower depreciation on a shrinking asset base. Cash research effort did not fall meaningfully; the non-cash charges around it did. The same pattern holds for the six-month comparison ($13.0m lower impairment, $8.3m lower D&A, $5.2m lower SBC).

6.2 Stock-based compensation is a third of the cost base

Roughly one dollar in every $3.70 of QuantumScape’s cost base is paid in stock, every year, without exception, since the de-SPAC. Cumulative SBC 2020 through H1 2026 is $693m. This is not a non-cash accounting artefact to be added back: it is the mechanism by which the share count more than doubled, and it is a direct, quantifiable transfer from existing shareholders to employees.

Which makes the treatment of Adjusted EBITDA important. FY2025 Adjusted EBITDA loss was $252.3m against a GAAP net loss of $435.1m. The $182.8m wedge is $127.5m of SBC plus depreciation and net interest. FY2026 guidance is an Adjusted EBITDA loss of $250–275m against a GAAP net loss running at roughly $400m annualised. Management’s headline profitability metric excludes the single largest recurring cost the company incurs, at a company whose only currency is its own equity. The gap should be held in view whenever the guidance is quoted.

6.3 The balance sheet — the genuine strength

The balance sheet is the best thing about QuantumScape and it should be stated without qualification.

At 2026-06-30: cash and equivalents $132.9m plus marketable securities $726.1m = $859.0m of liquidity, plus $13.7m of restricted cash pledged against facility leases and reported in other assets. Total assets $1,168.7m. Total liabilities of just $120.8m, of which the only debt is finance leases ($3.8m current + $26.3m long-term = $30.1m); operating lease liabilities are $37.0m. There are no borrowings, no convertible notes, no preferred stock, no mezzanine equity and no off-balance-sheet debt. The preferred line reads “100,000 shares authorized, none issued and outstanding.” Stockholders’ equity is $1,048.0m.

That last point matters more than it might appear. The two most damaging balance-sheet traps in this cohort — a redeemable preferred stack sitting ahead of the common (which converted Lucid’s apparent book value into a negative common deficit) and a convertible note complex marked at distressed prices — are simply absent here. QuantumScape’s capital structure is one class of economics: common equity. Its liquidity of $859.0m is 7.1x its total liabilities.

The securities themselves are conservatively invested: $75.7m in US money-market funds and $558.3m in US government and agency securities at 30 June 2026, the balance in commercial paper and corporate notes.

Two caveats. First, 82.0% of book equity is the cash pile. Book value per share is $1,048.0m / 619.1m = $1.693. The next-largest asset is net PP&E at $229.4m, against gross PP&E of $443.6m at 2025 year-end — the pilot-line asset base is already roughly 48% depreciated, and much of it is purpose-built equipment with limited resale value. Second, the accumulated deficit is $(3,992.6)m against paid-in capital of $5,041.5m: shareholders have contributed roughly $5.0bn and $4.0bn of it is gone.

6.4 Cash flow, cumulative burn, and runway

Cumulative free cash outflow since the de-SPAC is $1.79 billion. Cumulative operating loss is $2.41 billion. Cumulative capital raised is $2.47 billion. Roughly 72% of every dollar shareholders have contributed has been consumed.

Runway. H1 2026 consumed $111.8m of cash-plus-securities (from $970.8m to $859.0m), assisted by $17.2m of interest income and the $10.4m PowerCo receipt. Taking management’s own FY2026 guidance — Adjusted EBITDA loss of $250–275m plus capex of $27–37m, less roughly $33m of interest income and remaining PowerCo milestone payments — the annual burn is approximately $230m. That implies $859.0m / ~$230m ≈ 3.7 years, or roughly mid-2030, consistent with management’s Q3 2025 statement that runway “extends through the end of the decade.”

Note the awkward coincidence embedded in that number: the runway expires at approximately the same moment the industry expects mainstream solid-state production to begin. QuantumScape can fund itself precisely to the starting line, and not past it.

6.5 The quality-of-metric problem: “customer billings”

This is, in my judgement, the most important accounting finding in this report, and it requires care to state fairly.

In the Q3 2025 shareholder letter, management wrote: “Going forward, we plan to move away from providing updates on cash runway and will begin providing updates on customer billings.” The metric has since become the company’s headline evidence of commercial traction: $19.5m for FY2025, $11.0m in Q1 2026, $10.8m in Q2 2026.

Management’s own definition is disarmingly honest: “Customer billings as a metric represents the total value of all invoices issued by QS to our customers and partners in the period, regardless of accounting treatment… This operational metric is not a substitute for revenue under U.S. GAAP.”

Three observations follow.

(i) It has no anchor anywhere in the financial statements. It appears on no line of the income statement, the balance sheet or the cash-flow statement. There is not even an accounts receivable line on the balance sheet against which billings could be traced. Current assets consist of cash, marketable securities, and $10.1m of “prepaid expenses and other current assets.” A metric describing invoices issued, at a company with no receivables line and no revenue line, cannot be independently verified by any user of the financial statements.

(ii) The identifiable majority of it is an equity contribution from a related party. Q2 2026 billings were $10.8m. Note 10 of the same quarter’s 10-Q discloses that QuantumScape received $10.353m from PowerCo, and that “such amount was recorded as a capital contribution to Additional Paid-In Capital in the Consolidated Statement of Shareholders’ Equity upon legal extinguishment. No shares were issued related to this capital transaction.” The accounting rationale is ASC 730-20 (Research and Development Arrangements), applied because “there is a presumption of a repayment obligation due to the significant related party relationship between the parties,” combined with ASC 470-50, under which extinguishment transactions between related entities “may be in essence capital transactions.” The cash appears in financing activities on the cash-flow statement.

To be precise about what this does and does not mean: it does not mean the payment is fictitious or that PowerCo is doing QuantumScape a favour — PowerCo is buying real engineering work from a joint scale-up team. But the accounting conclusion that QuantumScape’s own auditors reached is that, because of the related-party relationship, the substance is closer to a capital transaction with a shareholder than to an arm’s-length sale. An investor treating $10.8m of “billings” as evidence of third-party commercial demand is reading it as management frames it, not as the accountants concluded.

(iii) The residual is unexplained. Of $21.8m of H1 2026 billings, only $10.4m is traceable to any line in the cash-flow statement. The other ~$11.4m — attributed by management to “a mix of customer development activities and ecosystem partner payments” — does not appear as revenue, as a receivable, or as an identifiable financing or operating inflow. The most likely treatments are a reduction of R&D expense or inclusion in other assets/liabilities, but the filings do not say, and this should be a direct question to the CFO (see the Open Questions section).

6.6 Returns on capital

ROIC and ROE are undefined in any meaningful sense. Trailing return on equity is approximately −37% (TTM net loss of ~$416m against average equity of ~$1.11bn), which measures burn rate, not returns. There is no invested capital generating a return; there is capital being consumed at a measurable rate.

Verdict: THE ECONOMICS DO NOT IMPROVE WITH SCALE, BECAUSE THERE IS NO SCALE. A fortress balance sheet attached to a sixteen-year-old research programme. The balance sheet is the asset; the income statement is the liability. Cost discipline is genuine and improving — but reducing the burn at a pre-revenue company extends the option’s expiry date without creating any value. The headline commercial metric is management-defined, unauditable from the financial statements, and largely an equity contribution from a 27.3% shareholder.

7. Capital Allocation

7.1 Sources of capital and dilution

Shares outstanding have risen from 252.1m (weighted, 2020) to 619.1m actual at 2026-06-30 — a 145% increase. In the last twelve months alone the weighted count rose 7.1%. Roughly 47.7m additional shares sit in outstanding options (3.2m), RSUs (31.6m) and PSUs (12.8m) — a further 7.7% of potential dilution, currently anti-dilutive because of the losses.

7.2 What was done well

Three things, and they should be credited properly.

The 2025 ATM was well executed. QuantumScape sold 29.5m shares for $264.2m net at an average of roughly $8.96 in a year whose low was $3.40 and whose close was $10.42. Raising into strength is exactly what a pre-revenue company should do, and it is the single best capital-allocation decision in the company’s public history. (The 2024 ATM at ~$5.16 was less impressive, and the August 2023 offering at ~$7.69 was reasonable.)

Cost discipline is real and accelerating. Capex fell from $158.8m (2022) to $36.3m (2025), and FY2026 capex guidance has been cut twice — from $40–60m at Q4 2025 and Q1 2026 down to $27–37m at Q2 2026 — with Q2 capex of just $4.6m. A 12% reduction in force in 2025 took headcount to ~700. Real estate has been shed aggressively: an 80,641 sq ft lease was terminated outright in July 2025 (with “no further obligations to the Landlord”), and in December 2025 the entire 61,100 sq ft building at 1762 Automation Parkway was subleased to Momentus for ~$11.5m of base rent through 2032 — an 8-K describing it as producing “a smaller operational footprint consistent with the Company’s technology licensing focus.” That is roughly 142,000 sq ft removed in eighteen months.

Governance hygiene is above average for the cohort. Clawback arrangements are in place for compensation received after 2 October 2023. Hedging and pledging of company securities are prohibited outright. Change-of-control arrangements are double-trigger with no 280G tax gross-ups. There are no special perquisites and no supplemental executive retirement benefits. The EPA option programme was fully sunset in 2025, with all recipients irrevocably waiving and forfeiting their options.

7.3 What was done poorly, or is structurally troubling

Shareholders have funded $2.47bn to produce zero revenue. That is the headline capital-allocation fact and no amount of process quality offsets it.

Executive compensation is disconnected from outcomes. From the 2026 proxy: CEO Dr. Siva Sivaram’s total compensation was $8,377,033 in 2025 and $19,606,478 in 2024. Aggregate 2025 compensation for the five named executives was approximately $24.8m — at a company with no revenue, against total G&A of $97.0m. Bonuses are paid in fully vested RSUs, which is why the Non-Equity Incentive Plan column reads “—” for every officer and why the headline totals sit in Stock Awards.

The 2025 bonus paid out at 100% of target for every named executive. The proxy states: “achievement of all goals under the 2025 Bonus Plan… resulting in a total payout of 100% of each NEO’s target bonus for 2025.” That was a year in which the stock traded as low as $3.40, revenue remained zero, and the anchor customer’s commitment was six months from being cut by 42%. PSU vesting was more discriminating — two of the 2023 PSU milestones and one 2024 milestone were achieved, vesting 50% of 2023 PSUs and 25% of 2024 PSUs — but a 100%-of-target annual bonus in that year is difficult to defend.

Until 2026, no incentive metric referenced shareholder returns. Every performance metric in the programme was an internal technical or operational milestone that management itself defined and against which management’s own board assessed performance. There was no TSR, no per-share metric, no return-on-capital metric, no cash-preservation metric. This changed in April 2026, and the change deserves credit: refresh grants are now at least 67% performance-based (75% for the CEO) and for the first time include relative TSR awards “tied to QS’s shareholder returns relative to peers.” That is a genuine structural improvement, though it arrives after five years and $2.4bn.

7.4 The insider record

This is the cleanest single finding in the report, because the census is complete. All 428 Form 4 filings in the trailing 60 months were retrieved and their XML parsed directly. The result:

Open-market purchases (transaction code P): zero. Insider sales: 29.61 million shares for $368.5 million across 348 transactions, at a weighted-average price of $12.45.

Not one officer, director or ten-percent holder has bought a single share of QuantumScape in the open market — through the fall from $132.73, through the $3.40 low of April 2025, or at any point since. The only codes that appear across the entire corpus are A (grants), S (sales), M (option exercises), F (tax withholding), C (conversion), G (gifts), J and X. The weighted-average selling price of $12.45 is 2.4x today’s $5.23.

Two patterns within the data are more informative than the total.

(a) 2025 was the heaviest selling year in the company’s history — heavier than the 2021 mania. Proceeds by calendar year: 2021 $120.9m, 2022 $51.1m, 2023 $27.5m, 2024 $26.4m, 2025 $129.0m, 2026 year-to-date $13.5m. Insiders sold more stock into the 2025 rally than they sold at the post-de-SPAC peak.

(b) There was a broad, precisely-timed selling cluster at the 2025 high. The stock peaked intraday at $19.07 on 2025-10-15. In the five weeks from 2025-10-01 to 2025-11-05, eight insiders sold 2.67 million shares for $42.3 million across 24 transactions:

Director Brad Buss disposed of his entire 700,000-share position in four tranches, the last at $18.41 on 2025-10-31 — within eleven sessions of the all-time-recent high. The CEO, the CFO, the CTO, the Chief Legal Officer, both co-founders on the board and three independent directors all sold in the same five-week window. Two months later, director Dipender Saluja sold a further 3.30m shares for $36.9m on 2025-12-12 and 2025-12-15.

The fair caveats: much of this is routine diversification for people whose net worth is concentrated in one illiquid position; a great deal of it will have been executed under 10b5-1 plans adopted earlier; Dr. Holme retains 10.37m Class B shares and Prof. Prinz 8.61m, so neither has exited; and selling by a founder who has held since 2010 says less than selling by a recent hire. None of that touches the finding that matters. Selling is ambiguous; buying is not. When a management team genuinely believes the market has mispriced its own technology by an order of magnitude, the cheapest and loudest way to say so is to buy stock with its own money. Across six years, 428 filings, and a 96% decline, nobody has bought a single share.

7.5 The structural conflict

QuantumScape’s largest shareholder is also its anchor customer, its principal funder, and its prospective perpetual non-exclusive licensee.

Volkswagen Group of America Investments held 68.2m Class A and 18.0m Class B shares at 2026-03-31 — 26.2% of the total vote, rising to 27.3% by 2026-06-30 — and designates two board seats under an amended and restated letter agreement dated 2024-07-05. Volkswagen therefore sits on both sides of every material negotiation QuantumScape conducts: it funds the programme, it will license the technology, it sets the milestones, and it votes on the board that oversees management’s compensation for hitting them.

The July 2026 amendment is what that conflict looks like when exercised: the funding maximum cut 42%, cost reimbursement replaced by milestone gating, and Statement of Work No. 1 terminated outright. Volkswagen is not behaving badly — it is behaving rationally, as any large customer with leverage would. The point is that QuantumScape has no counterweight.

Voting control compounds the issue. Class B shares carry ten votes each. All directors and executive officers as a group hold 51.3% of the Class B and 20.5% of the total vote on 0.9% of the Class A. Dr. Holme alone controls 11.0% of the vote; retired co-founder Prof. Prinz, who left the board in February 2026, retains 9.1%. Between insiders and Volkswagen, roughly 47% of the vote is controlled by parties holding a small fraction of the economics.

7.6 The financing question nobody is asking

In the Q3 2025 letter management disclosed, almost in passing: “We completed our at-the-market equity program before our shelf registration statement expired on August 10 [2025].”

No Form S-3 has been filed since 2022-07-29, and no 424B5 since 2023-08-04. QuantumScape therefore has no effective shelf registration and no registered capacity to sell stock today.

This should not be overstated, and the 10-K cover page tells you why: QuantumScape is a well-known seasoned issuer. A WKSI may file an automatic shelf registration statement (S-3ASR) that becomes effective immediately upon filing. Dilution capacity is therefore precisely one filing away, at any moment of management’s choosing.

Which makes the absence of that filing the informative fact. Management has not restored its shelf during eleven months in which the stock has traded between $4.77 and $19.07 — including an October 2025 window at $19.07 when raising would have been trivially easy and highly accretive. Two readings are possible: either management believes the balance sheet is genuinely sufficient to 2030 and sees no need, or it is unwilling to signal dilution into a falling market. Either way, a new S-3 filing would be a meaningful negative signal and should be watched.

Verdict: MIXED, TILTING NEGATIVE. The 2025 ATM execution, the capex and headcount discipline, the real-estate rationalisation, and the 2026 introduction of relative TSR are all genuine positives that distinguish QuantumScape favourably from much of its cohort. Against that: $2.47bn raised for zero revenue, a 145% increase in share count, a quarter of the cost base paid in stock, an executive team that took $24.8m in 2025 and a 100%-of-target bonus in a year the anchor customer was about to halve its commitment, a controlling shareholder sitting on both sides of every negotiation, and — across all 428 Form 4 filings in five years — $368.5m of insider selling against not one open-market purchase.

8. Changes and Headwinds — Last Two Years

8.1 The strategic changes

July 2024 — the licensing pivot. The Collaboration Agreement with PowerCo (8-K filed 2024-07-11) converted QuantumScape from a would-be manufacturer into a would-be licensor, with a contemplated IP Licence covering up to 40 GWh (expandable by 40 GWh) and a $130m pre-paid initial royalty. The stock rose 30.5%. Simultaneously, an amended letter agreement gave Volkswagen two designated board seats.

Leadership transition, completed. Founder Jagdeep Singh handed the CEO role to Dr. Siva Sivaram effective 2024-02-15, the culmination of a year-long succession Singh himself initiated; Sivaram had joined as President in September 2023 from Western Digital. Singh subsequently retired as Chairman, with Dennis Segers taking the chair effective 2025-01-01. Co-founder Prof. Dr. Fritz Prinz retired from the board on 2026-02-04 after more than fifteen years, “not… any disagreement with the Company.” Dr. Luca Fasoli joined as COO in May 2025 from Western Digital/SanDisk. Of the three founders, only CTO Dr. Timothy Holme remains in an operating role.

Board reconstituted toward the new strategy. Geoffrey Ribar (former CFO of Cadence Design Systems and of NVIDIA) joined 2026-01-29 — a finance and semiconductor operator. Dr. Ross Niebergall (former President of L3Harris’s Aerojet Rocketdyne segment; former CTO of L3Harris and Harris) joined 2026-03-04, three months before the QSAS aerospace-and-defence vertical was announced. The board is being rebuilt around licensing, semiconductors and defence rather than around automotive manufacturing.

July 2025 — the Amended and Restated Collaboration Agreement. PowerCo committed “up to $130.7 million” over two years for the joint scale-up team, and the IP Licence terms were amended to add up to 5 GWh for non-Volkswagen customers, bringing the contracted maximum to 85 GWh.

December 2025 — voluntary exchange transfer. QuantumScape notified the NYSE of its intent to withdraw and transferred its Class A listing to Nasdaq, with NYSE trading ending 2025-12-22 and Nasdaq trading beginning 2025-12-23. No reason was given beyond board authorisation. Not material to the thesis, but note that a great deal of third-party data — and several 2026 news wires — still identifies the company as “NYSE: QS.”

February 2026 — Eagle Line inaugurated and initial ramp begun.

June 2026 — the Honda agreement, a multi-year joint research agreement with Honda R&D covering solid-state battery development and manufacturing processes. Announced by press release on 2026-06-18; the stock rose 16.5% that day. No Item 1.01 8-K was filed, and Honda is not named in the Q2 2026 10-Q filed five weeks later.

July 2026 — the three verticals (QSEV, QSDC, QSAS) formally established, with general managers appointed for the data-centre and aerospace/defence units.

8.2 The headwinds

The PowerCo funding cut — the material event of the year. On 2026-07-16 the parties amended the Collaboration Agreement again. Statement of Work No. 1 and its cost-reimbursement structure were terminated and replaced with milestone-based payments tied to “the delivery and validation of battery cells over the next two years.” “Under the Amendment, the maximum aggregate amount the Company will receive from PowerCo for the program is $75.4 million, inclusive of amounts paid to date.” Against the prior $130.7m maximum, that is a 42.3% reduction, and the remaining headroom is smaller still because ~$10.4m has already been paid.

Two aspects compound it. First, the change in structure — from cost reimbursement to milestone gating — transfers execution risk from PowerCo to QuantumScape. Under cost reimbursement, QuantumScape was funded for effort; under milestone gating, it is funded for results, and only if PowerCo agrees the results were achieved. Second, the disclosure: the 8-K was filed 2026-07-22, the same day as the Q2 earnings release; the shareholder letter published simultaneously described the change only as “an amended set of milestones and payments” with no dollar figure; and the figure reached investors via the 8-K and Note 11 of the 10-Q filed two days later. The stock fell 12.9% on 2026-07-23 on 63.9m shares.

US EV demand has contracted. BEV share of US light-duty sales fell to 6% in H1 2026 from 7% a year earlier following the September 2025 tax-credit expiry, with the luxury segment — QuantumScape’s most plausible first market — falling from 22% to 14%. Hybrids hit a record 16%.

Battery price deflation continues. Pack prices reached $108/kWh in 2025 (−8% y/y) with $105/kWh forecast for 2026 and LFP packs at $50/kWh, steadily lowering the ceiling on any premium a solid-state cell can command.

Competitive convergence. Toyota (2027–28), Samsung SDI (~2027) and CATL (semi-solid 2026, solid-state ~2027–2030) have all closed the timing gap. Toyota’s electrolyte partner Idemitsu broke ground on a pilot plant on 2026-01-29.

Peer capitulation. SES AI, a lithium-metal peer of similar vintage, abandoned EV cells entirely in 2026 to pivot to AI materials discovery, drones and stationary storage.

Litigation, resolved. The securities class actions filed beginning January 2021 were settled, with a net $24.5m litigation charge taken in FY2024. This is now behind the company and is a one-time item to normalise out of the FY2024 G&A base — it is a substantial part of why FY2025 G&A fell 32% to $97.0m.

Verdict: THE CHANGES WEAKEN THE THESIS ON BALANCE. The strategic direction — licensing, cost discipline, market diversification, a board rebuilt around the new model — is coherent and mostly correct. But the two facts that actually moved the intrinsic value both moved it down: the anchor customer cut its maximum funding by 42% and shifted execution risk onto QuantumScape, and the end market the whole thesis rests on shrank. The offsetting positives — Honda, the verticals, Eagle Line progress — are announcements, not contracts.

9. Risk Analysis

The risk profile is unusual and worth naming precisely: near-zero financial risk and near-maximal business risk. The balance sheet essentially eliminates the financing failure mode that kills most pre-revenue companies. What remains is the pure question of whether the technology reaches qualified volume production before the money runs out and before the competition arrives — and, if it does, whether the licensing structure lets QuantumScape keep any of the value.

10. Valuation Discussion — Embedded Expectations

10.1 Building the enterprise value by hand

Neither aggregator can be used here, and the reasons are instructive.

ROIC.ai’s get_enterprise_value returns $3,088.9m for Q1 2026 because it nets only bs_cash_near_cash_item of $145.1m and ignores $759.6m of marketable securities — the identical failure mode previously logged on INFQ. Its Q2 2026 record is worse: market capitalisation of $4,438m with every cash and debt field null, so EV simply equals market cap. FactorsToday reports a $3.05bn market capitalisation, which counts Class A only and omits the 32.0m Class B shares. Neither figure should be quoted; both overstate the enterprise value by $650m–$1.0bn.

10.2 Why the usual multiples do not apply

There is no P/E (losses), no EV/EBITDA (negative), no EV/Sales (no sales), no P/FCF (negative). AZI’s valuation_index returns n_components = 1: P/B at 2.8798 in the 44.6th percentile of the stock’s own history, on a book value per share of $1.8161. With only one usable component, the composite percentile should not be quoted at all — and the one component available carries two problems of its own.

First, the BVPS is stale: $1.8161 corresponds to Q1 2026 equity, not Q2. On Q2 book equity of $1,048.0m and 619.109m shares, book value per share is $1.693 and the current P/B is 3.09x, not 2.88x.

Second, and more fundamentally, P/B is close to meaningless here in a specific way: 82% of QuantumScape’s book equity is the cash pile. “Price to book” for this company is very nearly “price to remaining cash,” and it mechanically improves as the company burns money and the stock falls. It cannot signal value; it signals only how much of the original cash is left.

The only useful framing is therefore the residual: what is the market paying for the technology, net of the cash?

On an enterprise-value basis, before crediting PP&E, the figure is ~$2.41bn.

10.3 The embedded-expectations anchor: QuantumScape’s own disclosed price

There is exactly one arm’s-length price for QuantumScape’s technology in the public record, and it is in the 10-K.

Under the contemplated PowerCo IP Licence Agreement, PowerCo would “pre-pay an initial royalty fee of $130 million, against which any future royalties due will be credited,” for a non-exclusive, limited, royalty-bearing licence covering “one or more PowerCo facilities that together have an annual capacity of up to 40 GWh, expandable by an additional 40 GWh”, plus — per the July 2025 amendment — “up to an additional 5 GWh… including for customers outside the Volkswagen Group, bringing the potential maximum production by PowerCo under the PowerCo IP License Agreement to 85 GWh annually.”

This is QuantumScape’s period-charter curve. Volkswagen has been a partner since 2012. It holds 27.3% of the vote and two board seats. Its own laboratories certified the A-sample endurance results. Nobody on earth has better information about whether this technology works. And this counterparty has agreed to pay $130 million up front for QuantumScape’s entire flagship automotive licensing economics at up to 85 GWh a year.

The public market is paying approximately $2.41 billion of enterprise value for the same asset — roughly 18.5x what the best-informed counterparty in the world agreed to pre-pay for the flagship licence.

Two fair objections, and the responses to them. Objection 1: the $130m is only an advance against ongoing royalties, not the total value of the licence. True, and important — the $130m is credited against future royalties, so it is a floor, not a ceiling. But a rational counterparty sizes an advance against expected near-term royalties; a $130m advance implies a royalty stream measured in tens of millions per year, not hundreds. Objection 2: PowerCo is only one licensee; the bull case requires several. Also true — and that is precisely the assumption the current price embeds, which the embedded-expectations tests below examine.

10.4 Reverse-engineering the royalty

QuantumScape has never disclosed the royalty rate, and this is the single largest uncertainty in any valuation of the company. The following is a labelled assumption set, bounded by two observations: PowerCo would not pre-pay $130m for something worth far more per year (which caps the rate), and QuantumScape would not license for nothing (which floors it).

If the $130m prepayment is credited against future royalties and licensed volume reaches the contracted 85 GWh maximum, the prepayment equals $1.53/kWh of a single year’s full-rate output. Against BNEF’s $105/kWh 2026 pack-price forecast and an implied cell price around $80/kWh, a royalty of 2–4% of cell revenue equates to roughly $1.60–$3.20/kWh. I use $2.50/kWh as the central assumption throughout.

10.5 What must be true for $2.41bn of enterprise value

Test 1 — does the contracted maximum even cover the cost base?

85 GWh × $2.50/kWh = $212.5m of gross annual royalty, at 100% utilisation of the full contracted PowerCo maximum, every year.

QuantumScape’s current annual operating expense is approximately $430m.

The entire maximum PowerCo licence, running flat out, does not cover half of QuantumScape’s present cost base. This single arithmetic is the most important number in the report. It does not mean the company cannot work — a licensor’s steady-state cost base should be far below a developer’s, and management is already cutting toward that. But it does mean that PowerCo alone can never justify the current price, no matter how well it executes.

Test 2 — what scale is required to support $2.41bn?

For a rational buyer to earn a 10% yield on $2.41bn — the minimum defensible for an asset this risky — QuantumScape needs roughly $240m of after-tax free cash flow, implying about $340m of pre-tax royalty against a materially reduced ongoing cost base of $100–150m. At $2.50/kWh, that requires 135–210 GWh of licensed production annually — that is 1.6x to 2.5x the entire contracted PowerCo maximum, and for scale it is roughly the total annual cell output of a top-five global manufacturer today.

Test 3 — apply the discount rate and the timing.

First licensed automotive production is realistically 2028–2030; QuantumScape has committed to no date, and the industry consensus for solid-state mass production is around 2030. Discounting $240m of 2032 free cash flow at a venture-appropriate 20% and capitalising at 12x yields roughly $1.0–1.2bn of present value — before any probability weighting for technical failure. To reach today’s $2.41bn one must assume either a materially larger licensee base than the only one under negotiation, or a discount rate far below what a pre-revenue single-technology company warrants, or both.

10.6 Scenario analysis

All scenarios assume the current 619.1m share count. Further dilution is not modelled and would reduce all three. Probabilities are deliberately not assigned — that is the reader’s judgement, and false precision would be worse than none.

BEAR — technology or timing failure. PowerCo does not execute the IP Licence, or executes it and the programme stalls at C-sample. QuantumScape continues burning ~$230m a year until the board capitulates. Residual value is remaining cash at that point plus a sale of the patent estate. Say $400–600m of cash remaining in 2029 plus $200–400m for >400 patents and applications. → $600m–$1.0bn equity value = $0.97–$1.62 per share.

BASE — the licence signs; PowerCo alone commercialises at moderate scale. PowerCo enters the IP Licence and pays the $130m; QuantumScape-based production reaches 30–50 GWh by the early 2030s at ~$2.50/kWh, generating $75–125m of royalty against an opex base cut to ~$120m. That is roughly break-even to modestly free-cash-flow positive. Value is today’s cash, less the ~$900m–1.1bn burned reaching that point, plus 10–12x a $30–60m steady free cash flow. → $1.2–1.8bn equity value = $1.94–$2.91 per share.

BULL — a multi-licensee platform. PowerCo signs and scales to the full 85 GWh; Honda converts its research agreement into a licence; one further top-ten OEM signs; and QSDC/QSAS deliver meaningful high-margin non-automotive royalties where price sensitivity is lower. 150–200 GWh at $2.50–3.50/kWh = $375–700m of royalty on a ~$150m cost base, i.e. $200–450m of free cash flow, capitalised at 12–15x and discounted six to eight years at 15–20%, plus residual cash. → $2.0–4.0bn equity value = $3.23–$6.46 per share.

The current price of $5.23 sits inside the upper half of the bull range. The market is not paying an option premium across a wide distribution of outcomes; it is paying close to the successful outcome, for an agreement that has not been signed.

10.7 The relative-value cross-check

QuantumScape trades at 3.8x its own liquidity; Solid Power at approximately 1.0x while actually recognising GAAP revenue, running a BMW i7 test vehicle, and burning under half as much. The technology premium over cash is roughly $2.4bn for QuantumScape and roughly $15m for Solid Power. That gap may be deserved — QuantumScape’s oxide separator and anode-free architecture are arguably the more differentiated asset, and it has the only external customer-lab validation in the group. But it is enormous, and it rests entirely on narrative rather than on any contracted economics.

Valuation summary (no recommendation, no price target). The market is underwriting: (i) that PowerCo signs; (ii) that PowerCo scales toward its contracted maximum; (iii) that at least one and probably two further licensees sign; (iv) that the new verticals convert to revenue; and (v) that all of this happens before the $859m runs out in roughly 2030. Each is plausible. All five together, at the price implied, is the bull case — and it is what the current price already discounts.

11. Variant Perception

11.1 What consensus believes

The prevailing view, visible across sell-side and retail commentary, runs roughly: QuantumScape has the best solid-state technology in the West, has now proven it can be manufactured (Eagle Line, Cobra), has a blue-chip partner ecosystem (Volkswagen, Honda, Murata, Corning), is broadening into high-value markets (AI data centres, defence), has a fortress balance sheet with a runway through the decade, and has just been de-rated to a level where the risk/reward is attractive. The stock is down 96% from its peak and 73% from October 2025 — the bad news is in the price.

Every clause is defensible. The technology is real, the balance sheet is real, the partners are real, and the de-rating is real.

11.2 The strongest bull case

Stated as strongly as the evidence permits:

1. The technology has been externally validated once, by the best possible judge. PowerCo’s own laboratories certified a 24-layer A-sample at >1,000 cycles and >95% capacity retention against a 700-cycle / 20%-loss standard. That is not marketing.
2. The safety argument is underrated and may be the real product. The ceramic separator is nonflammable and noncombustible. Competing next-generation approaches — silicon anodes, or lithium-metal with liquid electrolytes — carry safety hazards that must be compensated for at the system level, which can negate most of the cell-level gain. If solid-state’s commercial wedge turns out to be safety rather than energy density, QuantumScape’s architecture is differentiated in exactly the right dimension. Q2 2026 testing to IEC 62660-2 and SAE J2464 (nail penetration, external short, thermal stability to 300 °C) supports this.
3. The defence angle is structurally sound. Conventional lithium-ion depends on graphite “almost exclusively sourced from China.” An anode-free architecture eliminates that dependency. Defence customers pay for sovereignty, not $/kWh — the one customer set where a premium cell can earn a genuine premium. QSAS has already shipped cells to a major American defence prime, and the board hired an Aerojet Rocketdyne veteran to lead the effort at board level.
4. There is no financing cliff. $859m of liquidity against $120.8m of total liabilities and $30.1m of finance leases. No converts, no preferred, no borrowings. Nearly four years of runway with no covenant, no maturity wall and no forced seller.
5. The de-rating has been brutal and mechanical. The stock is at 3.09x book against a business whose book is 82% cash. Much of the 2026 decline is the unwind of a retail momentum trade, not a change in fundamentals.
6. Optionality is genuinely convex. If solid-state works at scale, the addressable royalty pool is enormous, and QuantumScape holds >400 patents around the only separator material it knows of that does the job.

11.3 The strongest bear case

1. Sixteen years, $2.4bn of operating losses, $1.8bn of cash burned, and zero revenue. The 10-Q’s own words: “Planned principal operations have not yet commenced.”
2. The anchor customer is contracting, not expanding. PowerCo’s maximum funding cut 42% to $75.4m inclusive of amounts paid, cost reimbursement replaced by milestone gating, Statement of Work No. 1 terminated — and the flagship licence still unsigned, with the 10-K conceding that if milestones are missed “PowerCo has no obligation to enter into the PowerCo IP License Agreement.”
3. The headline commercial metric is largely an equity contribution from a related party. $10.4m of Q2’s $10.8m of “customer billings” was booked to additional paid-in capital under ASC 730-20 and flows through financing activities.
4. The moat is being contractually given away. A perpetual, non-exclusive licence with sublicensing rights to the largest shareholder; jointly-owned separator IP that partners may exploit “without requiring our approval”; and those partners are Volkswagen, PowerCo, Murata and Corning.
5. The economics do not work at contracted scale. 85 GWh at $2.50/kWh is ~$213m of royalty against a $430m cost base.
6. The target is moving away. Pack prices $108 → $105/kWh with LFP at $50/kWh; US BEV share 7% → 6% and luxury BEV 22% → 14%; Toyota, Samsung SDI and CATL converging on the same window.
7. Nobody inside has ever bought a share. Zero code-P purchases across all 428 Form 4 filings in five years, against $368.5m of insider sales at a weighted-average $12.45 — including a $42.3m, eight-insider cluster (CEO, CFO, CTO, CLO, both founder-directors and three other directors) in the five weeks around the October 2025 high.
8. The tape offers no support. Negative Sharpe on every horizon out to five years; 110 sessions of bearish EMA configuration; momentum and quality both zeroed in the factor model.

11.4 The factor-positioning read

The factor-model evidence adds something the fundamental analysis cannot: an empirical description of what this stock is in the market’s eyes.

Read within the “Base + Sector + Industry” model (R² 30.4%), the loadings are: LowVolatility −1.565 (the single largest, and deeply negative — this is a maximum-volatility name), Market +1.514, SmallSize +1.428, Liquidity −0.775, Industry: Clean Energy +0.608, Industry: Lithium & Battery +0.096. Momentum is zeroed in all four nested models. Quality is zeroed. Value decays from +0.369 in the Base model to +0.154 with sector stripped and to zero in the richer models.

The interpretation is clean, and it is why the framing in Claude’s Take is evidence-based rather than asserted. There is no momentum trade here and there is no value trade here. What there is, is a high-beta, small-cap, maximum-volatility, illiquidity-exposed beta expression of the clean-energy complex — whose single closest factor sibling, at 0.981 similarity, is an exchange-traded fund (Invesco WilderHill Clean Energy). R² is only ~30% and idiosyncratic volatility is 74.9% annualised, meaning roughly 70% of the variance is company-specific news. That is why one headline moves the stock 15–35% in a session, and it is why shorting it is a good way to be right about the fundamentals and lose money anyway.

Where consensus may be offsides is subtle. The bulls are not wrong that the stock is cheap relative to its own history. They are wrong, in my reading, about what they are being paid for that cheapness. A 3.09x multiple on a book that is 82% cash is not a valuation signal; it is a measure of how much of the original money is left. And the market’s own positioning — a clean-energy ETF proxy with no momentum, no quality and no durable value loading — says that whatever is holding the price at $5.23, it is not a fundamental constituency that has done this arithmetic.

11.5 The five assumptions that matter, and what would falsify each

My variant perception, stated plainly: consensus is debating whether the technology works. That is the wrong question, and it is why the price is where it is. The technology probably does work — PowerCo’s own laboratory said so in January 2024. The right question is whether QuantumScape can capture enough of the value it creates, given that it has chosen to license non-exclusively and in perpetuity to a counterparty that owns 27.3% of it, sits on its board, sets its milestones, jointly owns the foreground IP on its core component, and just cut its funding by 42%. On the disclosed contracted terms — 85 GWh maximum, $130m advance — the answer is that it cannot capture enough to justify $2.41bn. That, not technical risk, is the variant view.

12. Fact vs. Interpretation

13. Open Questions

1. What is the royalty rate in the PowerCo IP Licence Agreement? It has never been disclosed and it is the single most important unknown in the valuation. Every royalty figure in the valuation section is a labelled assumption derived from one data point.
2. Where do the non-PowerCo “customer billings” appear in the financial statements? Of $21.8m in H1 2026, only $10.4m is traceable (the PowerCo financing line). There is no revenue line, no receivables line, and no disclosed treatment for the remaining ~$11.4m. Direct question for the CFO.
3. What specifically triggered the 42% cut to the PowerCo programme? Was it a missed technical milestone, a change in PowerCo’s own capacity plans, a re-scoping toward larger-format cells, or a negotiating outcome? The 8-K says only that the milestones were updated.
4. Of the “more than 400 U.S. and foreign patents and patent applications,” how many are granted? And what is the earliest expiry of the fundamental separator claims? Priority dates in the 2012–2015 range imply core expiries beginning around 2032–2035 — potentially before meaningful licensed volume.
5. What are the actual milestones that trigger entry into the IP Licence? They are the gating condition for the entire thesis and have never been described publicly.
6. When will a new S-3 shelf be filed, and at what price? QuantumScape is a WKSI and could file an automatically effective shelf tomorrow. It has not done so since 2025-08-10.
7. Is the Honda agreement exclusive in any field, and does it carry any option to license? No Item 1.01 8-K was filed and Honda is not named in the subsequent 10-Q.
8. What is QuantumScape’s projected cost per kWh at scale? The company has never published one. Without it, the anode-free cost advantage cannot be evaluated against a $50/kWh LFP pack.
9. What is the steady-state opex of a licensing-only QuantumScape? The base and bull cases both require a cost base of $100–150m against $430m today. Management has never guided to a terminal cost structure.
10. Has any customer other than PowerCo run independent endurance testing? The January 2024 validation is the only external result in the public record, and it is now two and a half years old and covered A-samples.
11. What does the QSAS defence-prime engagement actually consist of? Cells have been shipped. Is there a development contract, a programme of record, or a funded evaluation?
12. Why did QuantumScape move from the NYSE to Nasdaq in December 2025? No reason was given beyond board authorisation.

14. What Must Be True

14.1 The bull case

For the bull case to be correct, all of the following must hold:

1. PowerCo executes the IP Licence Agreement and pays the $130m initial royalty. The gating event for everything else.
2. QuantumScape’s cells clear automotive qualification — C-samples, production part approval, and serial production — at consistency and yield levels achievable on partner equipment, not just on the Eagle Line.
3. At least one non-Volkswagen licensee signs real economics, converting the “four Top-10 OEM relationships” from research agreements into royalty-bearing contracts.
4. Licensed volume reaches 135–210 GWh annually, or the royalty rate is materially above the $2.50/kWh assumed here — because 85 GWh at $2.50/kWh does not cover today’s cost base.
5. QuantumScape’s steady-state operating cost falls to $100–150m from $430m, without gutting the R&D that keeps the technology ahead.
6. Solid-state commands a durable price premium over a ~$50/kWh LFP pack in 2030, or the defence and data-centre verticals deliver enough premium-priced volume to compensate.
7. All of this happens before roughly mid-2030, when the current balance sheet is exhausted, without a materially dilutive raise at a depressed price.

Falsification test for the bull case: If, by the end of Q2 2027, PowerCo has not executed the IP Licence Agreement and paid the $130m initial royalty — or if a further amendment reduces the programme again — the bull case is broken, not delayed. The company will then have spent three full years since the July 2024 Collaboration Agreement without converting its only contractual pathway into a licence, while burning approximately $700m more. A second falsifier: if Honda’s research agreement passes its first anniversary (June 2027) without converting to a supply or licence arrangement, the “four Top-10 OEM customers” framing should be treated as marketing rather than as a pipeline.

14.2 The bear case

For the bear case to be correct:

1. PowerCo either declines to sign the IP Licence, or signs and scales far below the 85 GWh maximum — the July 2026 amendment being the leading indicator.
2. Automotive qualification slips beyond 2030, by which time the LFP price umbrella has fallen further and Toyota, Samsung SDI or CATL have commercialised.
3. The perpetual non-exclusive licence and jointly-owned separator IP allow partners to internalise the process knowledge, leaving QuantumScape with a royalty on a shrinking share of the value it created.
4. The new verticals stay at the “engaged with ODMs” stage, never converting to contracted revenue.
5. The balance sheet is consumed to roughly 2030 and the company must raise into weakness, or accept a distressed outcome.

Falsification test for the bear case: If QuantumScape reports GAAP revenue — real revenue, recognised on the income statement, from a non-related party — of $25m or more in any four-quarter period before the end of 2028, the bear case is broken. That would demonstrate arm’s-length commercial demand at a scale the licensing model can compound from, and would retire the central objection that the only cash the company has ever collected from a customer was booked as a capital contribution from its own shareholder. A second falsifier: PowerCo executing the IP Licence and a second, non-Volkswagen OEM signing a royalty-bearing licence within the same twelve months — which would convert QuantumScape from a single-customer research programme into a genuine licensing platform and would justify a materially different valuation framework than the one set out above.

15. Source Appendix

The full source appendix is provided as Appendix B to this report.

Appendix A — Diligence Questionnaire

QuantumScape Corporation (NASDAQ: QS) · Report date 2026-07-31 · Price reference $5.23 (2026-07-30 close)

A standard diligence questionnaire, answered for this company. Answers are labelled Fact / Interpretation / Assumption where the distinction matters. Where a question does not map to a pre-revenue development-stage company, that is stated and the correct analogue is given.

General

What thoughtful questions have other investors asked about this company?

The debate has been unusually well-framed by the bull side and unusually poorly framed by the bear side. The genuinely thoughtful questions circulating are:

• Can the Cobra separator process hold quality at throughput? This is the right technical question. Making one good separator is a laboratory result; making millions at consistent thickness, density and defect rate is the company. The Eagle Line’s >90% core-tool uptime is the first partial answer.
• Is the licensing model a strength or an admission? Bulls read “capital-light” as an elegant sidestep of gigafactory capex. Bears read it as an admission that QuantumScape could never fund manufacturing. Both are right; the question is what it costs in value capture, which the valuation section of this article addresses.
• Does the balance sheet remove the bear case? $859m and no debt genuinely removes the financing bear case. It does not remove the value-capture bear case, and much commentary conflates the two.
• Is QuantumScape a takeover target? Raised repeatedly in 2026 trade press. The logic is that scarce IP plus a funded balance sheet plus a depressed price is an attractive combination. The counter is that any acquirer must negotiate around Volkswagen’s 27.3% vote and two board seats, and around a perpetual non-exclusive licence that may already have been granted to Volkswagen’s subsidiary. Interpretation: the dual-class structure and the PowerCo relationship make a hostile approach essentially impossible and a friendly one hostage to Volkswagen’s price.

The question almost nobody is asking, and the one this report is built on: what did the best-informed counterparty in the world actually agree to pay for this technology? The answer is in the 10-K — $130 million pre-paid, for up to 85 GWh a year — against a $2.41bn enterprise value.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low?

Not applicable — there are no earnings. QuantumScape has recorded a loss in every period of its existence. The correct analogue is spending, and spending is past its cyclical peak: total operating expense peaked at $525.2m in FY2024 and has fallen to a $430m annualised run-rate, with capex down from $158.8m (2022) to a guided $27–37m for FY2026.

Driven by the external environment or internal actions?

Both, and it is worth separating them. Internal: a 12% reduction in force in 2025, ~142,000 sq ft of real estate shed (an 80,641 sq ft lease terminated July 2025, a 61,100 sq ft building subleased to Momentus December 2025), and two successive cuts to FY2026 capex guidance. External: the July 2026 PowerCo amendment cut the maximum programme contribution by 42%, which reduces incoming cash irrespective of QuantumScape’s own actions.

How stable are revenues?

There are none. The nearest management-defined analogue, “customer billings,” is explicitly volatile by management’s own description — “customer billings may vary from quarter to quarter due to fluctuations in activity as we progress through various phases of engagement” — and the sequence bears that out: $12.8m (Q3 2025), ~$6.7m (Q4 2025, derived), $11.0m (Q1 2026), $10.8m (Q2 2026). Fact: the metric appears on no line of the income statement, balance sheet or cash-flow statement, and the largest identifiable component of it ($10.4m in Q2 2026) is a capital contribution to APIC from a related party under ASC 730-20.

Outlook for products/services?

One product exists in prototype: the QSE-5, a ~5 Ah cell at >800 Wh/L with <15-minute 10–80% fast charge, currently at the B1-sample stage of the automotive A/B/C qualification ladder. Larger formats have been demonstrated on Cobra. C-samples, production part approval and serial production are all still ahead, on no publicly committed timeline.

How big will this market be — growing, shrinking, domestic or international?

The battery market is enormous and growing globally, but the specific slice QuantumScape needs is shrinking in its home geography. US BEV share fell to 6% of light-duty sales in H1 2026 from 7% a year earlier after the September 2025 federal tax-credit expiry, with the luxury BEV segment — the natural first home for a premium cell — falling from 22% to 14%. Hybrids reached a record 16%. QuantumScape’s realistic path is international (Volkswagen’s European plants) and non-automotive (data centres, defence) rather than domestic automotive.

More importantly, the price of the market is falling: BNEF puts 2025 pack prices at $108/kWh (−8% y/y) with $105/kWh forecast for 2026 and LFP packs at $50/kWh. Interpretation: the addressable revenue pool is growing in kWh and shrinking in dollars per kWh, and QuantumScape’s product must clear the falling bar, not the 2020 bar.

Business Quality & Competitive Moat

Is the industry getting more or less competitive?

More. In 2020, QuantumScape was widely perceived to have a multi-year lead in solid-state. By 2026, Toyota targets a solid-state EV in 2027–28 (its electrolyte partner Idemitsu broke ground on a pilot plant on 2026-01-29), Samsung SDI targets ~2027 limited production, and CATL plans semi-solid cells in 2026 with solid-state around 2027–2030. Solid Power already has a BMW i7 test vehicle on the road. QuantumScape’s window sits inside the field, not ahead of it.

How profitable is the business (ROIC, ROE)?

It is not. ROIC is undefined. Trailing ROE is approximately −37% (TTM net loss ~$416m against average equity ~$1.11bn), which measures burn rate rather than returns. Cumulative operating loss since 2020 is $2.41bn; cumulative free cash outflow $1.79bn.

How profitable is the industry — how many competitors, what barriers to entry?

Conventional cell manufacturing is a low-return, capital-intensive scale business in the digestion phase of a capital cycle, with Chinese producers structurally advantaged on cost. Barriers to entry at the manufacturing level are capital and process yield — high, but surmountable by anyone with a balance sheet. Barriers at the materials level are genuinely high, which is where QuantumScape’s asset sits.

Can the business be easily understood?

Yes, unusually so. There is one product, one segment, one anchor customer, no revenue, and a balance sheet that is 82% cash and securities. The complexity is entirely technical, not financial. The three things an investor must judge are: does the separator work at volume; will PowerCo sign; and what royalty will it pay.

Can it be undermined by foreign low-cost labour?

Not by labour, but decisively by foreign low-cost capital and scale. Chinese cell makers produce at $84/kWh against $121–131/kWh in North America and Europe. QuantumScape’s counter — and it is a real one — is that the anode-free architecture eliminates dependence on graphite anode material that is “almost exclusively sourced from China,” which is precisely why the aerospace-and-defence vertical (QSAS) is the most economically interesting of the three.

Do brands matter?

No. Automotive OEMs and defence primes qualify on specification, safety, cost and supply security. “QuantumScape” as a consumer brand has no value. Retail-investor brand recognition, however, has considerable stock-price value — which is a different thing and is one reason the shares carry 75% annualised idiosyncratic volatility.

What is the nature of competition?

Multi-front. QuantumScape competes against: (i) incumbent LFP/NMC lithium-ion on price; (ii) other solid-state developers on time-to-market; (iii) vertically integrated OEM-backed programmes (Toyota, CATL, Samsung SDI) that capture full cell economics rather than a royalty; and (iv) alternative next-generation chemistries (silicon anode, lithium-metal with liquid electrolyte) on the safety and performance axes.

Customers’ switching costs?

For QuantumScape, essentially none — there is no installed base. Prospectively, automotive qualification creates high switching costs once a cell is designed into a vehicle platform, because requalification is a multi-year process. That is the moat QuantumScape is trying to buy, and it has not bought it yet.

Is there a moat?

No demonstrable moat. Applying Greenwald’s tests: market-share stability cannot be tested (no share) and ROIC-above-WACC cannot be tested (no returns). The only candidate is intangibles — >400 patents and patent applications plus process know-how — and QuantumScape’s own risk factors disclose two structural erosions: it intends to grant PowerCo a perpetual licence limiting its ability to prohibit exploitation by “PowerCo and its sublicensees… in perpetuity,” and jointly-owned foreground IP on the ceramic separator itself may be used, licensed and improved by partners “without requiring our approval.” The partners with that access are Volkswagen, PowerCo, Murata and Corning.

Financial Condition & Balance Sheet

Assets not fully recognised on the balance sheet?

Yes, and this is the crux of the bull case. The entire intellectual-property estate — >400 patents and patent applications, the separator composition developed over more than ten years, and the Cobra process know-how — is carried at essentially zero. R&D has been expensed as incurred throughout: $1,833m since 2019 alone. Book value per share of $1.693 therefore understates economic value if the technology works, and overstates nothing if it does not (since 82% of book is cash). Interpretation: this is precisely why the stock is an option rather than a security with a determinable intrinsic value — the asset is unbooked and binary.

Also unrecognised: $13.7m of restricted cash reported in other assets (pledged against facility leases), and the ~$11.5m of base rent receivable over the Momentus sublease through 2032.

Off-balance-sheet liabilities?

Minimal and fully disclosed. Operating lease commitments of ~$7.1m over the next twelve months and ~$41.5m thereafter (already capitalised as a $37.0m lease liability). Non-cancellable service and purchase commitments of ~$2.6m over twelve months and ~$2.2m thereafter through 2027. No guarantees, no unconsolidated entities, no pension obligations, no purchase-obligation overhang. Fact: the securities class actions filed from January 2021 were settled with a net $24.5m charge in FY2024 and are behind the company.

How conservative is the accounting?

Conservative on the balance sheet; aggressive in the investor communications. On the balance sheet: all R&D is expensed, no development costs are capitalised, a full valuation allowance is held against every deferred tax asset, marketable securities are held at fair value through OCI, and — the strongest signal — the PowerCo receipts are treated as capital contributions rather than as revenue under an ASC 730-20 related-party presumption. That is the conservative choice, and QuantumScape’s auditors (Ernst & Young LLP) made it.

In the investor communications: Adjusted EBITDA excludes $115–130m a year of stock-based compensation at a company whose only currency is equity; “customer billings” is a management-defined metric with no statement anchor; and the $18.6m Q2 R&D “decline” is $13.6m lower impairment and $5.6m lower depreciation. Interpretation: the accounting is honest and the framing is promotional — an investor reading only the shareholder letters would form a materially more favourable view than one reading only the 10-Q.

How CapEx-hungry is the business?

Historically very; prospectively, by design, not at all. Capex peaked at $158.8m (2022) and is guided to $27–37m for FY2026, with Q2 capex of $4.6m. The whole point of the 2024 licensing pivot was to push gigafactory capital onto PowerCo and other licensees. Cumulative capex since 2020 is $507.6m against gross PP&E of $443.6m at 2025 year-end — of which net PP&E is now $229.4m, i.e. the asset base is roughly 48% depreciated, much of it purpose-built pilot equipment with limited resale value.

Capital Allocation & Management

How much FCF does the business generate, how does management use it, what is the philosophy?

Free cash flow is negative $1,788.5m cumulatively since 2020 and negative $130.9m in H1 2026. There is no free cash flow to allocate; the allocation question is how the raised capital has been deployed. The answer: $2,468m raised, $2,410m of cumulative operating losses, $507.6m of capex, and $693m of stock-based compensation. Roughly 72% of every dollar contributed by shareholders has been consumed.

The stated philosophy is now “capital-light licensing”: preserve the balance sheet, cut fixed costs, transfer manufacturing capital to partners, and monetise through royalties. Interpretation: strategically correct and executed with real discipline since 2024 — but it is a philosophy adopted after $2bn was spent on the prior one.

Significant acquisitions recently?

None, ever. QuantumScape has made no acquisitions. It has made dispositions of a sort — terminating an 80,641 sq ft lease (July 2025) and subleasing a 61,100 sq ft building to Momentus (December 2025) for ~$11.5m of base rent through 2032.

Buying back shares?

No, and it should not. A pre-revenue company with a four-year runway repurchasing stock would be indefensible.

Issuing large amounts of new shares to insiders?

Yes, persistently. Stock-based compensation has run 21–35% of total operating expense in every year since 2020 — $693m cumulatively. Roughly one dollar in every $3.70 of the cost base is paid in stock. Outstanding potential dilution is 47.7m shares (3.2m options, 31.6m RSUs, 12.8m PSUs), a further ~7.7% of shares outstanding. Total share count has risen 145% since 2020.

Compensation policy of directors/management?

Fact: CEO Dr. Siva Sivaram’s total compensation was $8,377,033 in 2025 and $19,606,478 in 2024. Aggregate 2025 compensation for the five named executives was ~$24.8m, against total G&A of $97.0m at a company with no revenue. Annual bonuses are paid in fully vested RSUs (hence the “—” in the Non-Equity Incentive column). Non-employee directors receive $80,000 in cash plus equity.

Fact: the 2025 bonus plan paid out at 100% of target for every named executive — in a year the stock touched $3.40, revenue was zero, and the anchor customer’s commitment was six months from a 42% cut. PSU vesting was more discriminating: 50% of 2023 PSUs and 25% of 2024 PSUs vested.

Fact and genuine improvement: for the April 2026 refresh grants, at least 67% of NEO equity (75% for the CEO) is performance-based and includes, for the first time, relative TSR awards tied to shareholder returns versus peers. Until 2026, every performance metric was an internal technical or operational milestone that management defined and the board assessed. Other positives: clawback arrangements for compensation received after 2 October 2023; hedging and pledging prohibited outright; double-trigger change-of-control with no 280G gross-ups; no special perquisites or supplemental retirement benefits; and the EPA option programme fully sunset in 2025 with all recipients irrevocably forfeiting their options.

Motivations of management?

The compensation structure has, until April 2026, rewarded technical milestone achievement rather than value creation — which is arguably appropriate for a research organisation and inappropriate for one whose shareholders have lost 96%. The introduction of relative TSR corrects this, five years late.

The starker signal is ownership, and here the census is complete: all 428 Form 4 filings of the trailing 60 months were retrieved and parsed.

Fact: there is not one open-market purchase (transaction code P) by any officer, director or ten-percent holder in the entire corpus. Against that, $368.5 million of insider sales across 348 transactions and 29.61 million shares, at a weighted-average price of $12.45 — 2.4x today’s $5.23. Largest sellers: co-founder and director Prof. Dr. Fritz Prinz $68.3m; co-founder and CTO Dr. Timothy Holme $61.6m; Chief Development Officer Dr. Mohit Singh $57.0m; Chief Legal Officer Michael McCarthy $41.7m; director Dipender Saluja $41.1m; CFO Kevin Hettrich $22.7m; founder and former CEO Jagdeep Singh $20.5m; and CEO Dr. Siva Sivaram $2.0m.

Fact: 2025 was the heaviest selling year in the company’s history — $129.0m, exceeding even 2021’s $120.9m at the post-de-SPAC peak. And there was a broad, tightly-timed cluster at the top: in the five weeks from 2025-10-01 to 2025-11-05, straddling the 2025-10-15 intraday high of $19.07, eight insiders sold 2.67m shares for $42.3m — the CEO ($2.0m at $16.61–$17.05), the CFO, the CTO, the Chief Legal Officer, both founder-directors, and three other directors. Director Brad Buss sold his entire 700,000-share position in four tranches, the last at $18.41 on 2025-10-31.

Interpretation: selling is ambiguous — much of it is legitimate diversification, a great deal will have been executed under previously-adopted 10b5-1 plans, and neither founder has fully exited (Holme retains 10.37m Class B shares, Prinz 8.61m). Buying is not ambiguous. A management team that believed the market was mispricing its own technology by an order of magnitude had the cheapest and loudest way to say so, and across six years, 428 filings and a 96% drawdown has never once used it.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer?

No. QuantumScape Corporation is a Delaware corporation and a domestic US filer (10-K/10-Q/DEF 14A). Class A common stock trades on Nasdaq under “QS” — it transferred voluntarily from the NYSE, with NYSE trading ending 2025-12-22 and Nasdaq trading beginning 2025-12-23. Holders receive Form 1099, not K-1. Note that a great deal of third-party data still identifies the company as “NYSE: QS.”

There is a dual-class structure: Class A carries one vote, Class B carries ten. At 2026-06-30 there were 587.1m Class A and 32.0m Class B shares. Volkswagen Group of America Investments holds 26.2–27.3% of the total vote; all directors and executive officers as a group hold 51.3% of the Class B and 20.5% of the total vote on 0.9% of the Class A.

Dividend policy?

None, and none is conceivable. QuantumScape has never paid a dividend and there have been no splits — which is why adjusted and unadjusted prices in the price history are identical.

How profitable is the business?

It is not, and has never been. See above.

Is net income diverging from cash from operations?

Yes, structurally and in the expected direction. FY2025 net loss $(435.1)m against operating cash outflow of $(242.5)m — a $192.6m gap, essentially all non-cash: $127.5m of stock-based compensation plus depreciation and asset write-offs. H1 2026: net loss $(199.0)m against operating cash outflow of $(116.3)m, a gap of $82.7m ($57.8m SBC, $28.1m D&A, $5.1m ROU amortisation, $1.9m PP&E write-offs, less $8.3m of securities accretion).

The divergence is benign but must not be read as quality. For a normal company, OCF exceeding net income signals earnings quality. Here it signals only that a quarter of the cost base is settled in shares rather than cash — which is a transfer to employees from shareholders, not a saving.

What multiples apply?

Almost none. No P/E (losses), no EV/EBITDA (negative), no EV/Sales (no sales), no P/FCF (negative). AZI’s own-history valuation_index returns n_components = 1 — only P/B is available, at 2.8798 in the 44.6th percentile, computed on a stale Q1 book value per share of $1.8161. On Q2 equity of $1,048.0m and 619.109m shares, book value per share is $1.693 and the current P/B is 3.09x. With only one defensible component, the composite percentile should not be quoted.

And P/B is nearly meaningless here for a second reason: 82% of book equity is the cash pile, so “price to book” is close to “price to remaining cash” and mechanically improves as the company burns money. The only useful framing is the residual — market capitalisation of $3,237.9m less $859.0m of liquidity less $229.4m of net PP&E leaves ~$2,149m ascribed to the IP and the licensing option, or ~$2,409m of enterprise value.

Note on vendor data: ROIC.ai’s get_enterprise_value returns $3,088.9m for Q1 2026 because it nets only $145.1m of cash and ignores $759.6m of marketable securities; its Q2 2026 record has every cash and debt field null. FactorsToday reports a $3.05bn market capitalisation, which counts Class A only. Both were rebuilt by hand from the filed balance sheet.

Risks & Downside

What factors would cause the stock to decline?

In rough order of impact: (1) PowerCo declining to execute the IP Licence Agreement, or a further downward amendment to the programme; (2) a technical setback in scaling the Cobra process or the Eagle Line, or a partner reporting cycle-life or consistency failures at multilayer volume; (3) a competitor — Toyota, Samsung SDI, CATL — announcing commercial solid-state production ahead of QuantumScape; (4) the filing of a new S-3 shelf and restart of an at-the-market programme at depressed prices; (5) continued deterioration in EV demand or continued LFP price deflation; (6) a further quarter of “customer billings” that resolves, on inspection, into related-party capital contributions; (7) departure of CTO and co-founder Dr. Timothy Holme, the last founder in an operating role.

Risk of a catastrophic loss?

Moderate on a multi-year view, but the path matters. There is no financing failure mode in the near term: $859.0m of liquidity against $120.8m of total liabilities, only $30.1m of finance-lease debt, no borrowings, no convertible notes, no preferred stock, no mezzanine equity, and roughly 3.7 years of runway to about mid-2030. There is no covenant, no maturity wall and no forced seller. Catastrophic loss requires the technology to fail and the balance sheet to be exhausted, which is a 2029–2031 question, not a 2026 one.

Chance of a total loss?

Low. A total loss requires >400 patents and patent applications — including “broad fundamental patents around our core technology” on the only separator material QuantumScape knows of that cycles lithium at automotive current densities without dendrites — to be worth zero, and $859m of cash to be fully consumed with nothing recoverable. The far more likely downside outcomes are a distressed sale of the IP estate or an orderly wind-down returning residual cash. The bear scenario in the valuation section lands at $0.97–$1.62 per share, not zero.

The corollary matters for positioning: this is why the memo’s Claude’s Take says AVOID but not a short. A fortress balance sheet, a scarce patent estate, persistent takeover speculation, 75% annualised idiosyncratic volatility, and a heavy retail constituency (23.8m shares and ~$170m of dollar volume a day) make this a name where one can be right about the fundamentals and lose money on the position.

Recent News & Events

Has the business environment changed recently?

Yes, materially, and in two directions.

Against: the anchor customer contracted. On 2026-07-16 PowerCo cut its maximum contribution to the joint scale-up programme from $130.7m to $75.4m, inclusive of amounts paid to date — a 42.3% reduction — terminated Statement of Work No. 1, and replaced cost reimbursement with milestone-gated payments, transferring execution risk to QuantumScape. Separately, US BEV share fell to 6% in H1 2026 from 7%, with luxury BEV share down from 22% to 14%, and lithium-ion pack prices continued to deflate toward $105/kWh with LFP packs at $50/kWh.

For: the Honda R&D joint research agreement (announced 2026-06-18) added a fourth Top-10 OEM relationship; the Eagle Line was inaugurated in February 2026 and reached >90% core-tool uptime; larger-area Cobra separators were demonstrated; and three business verticals were established (QSEV, QSDC for AI data centres, QSAS for aerospace and defence), with QSAS shipping QSE-5 cells to “a major American defense prime.”

Significant acquisitions?

None.

Change in accounting policies?

No policy change. The notable accounting treatment — first appearing in Q2 2026 — is the recording of PowerCo programme receipts as a capital contribution to additional paid-in capital under ASC 730-20 and ASC 470-50, rather than as revenue or as a liability. $10.353m was so recorded in Q2 2026. Ernst & Young LLP was ratified as auditor for FY2026 at the 3 June 2026 annual meeting.

Recent changes — new markets, facilities, management?

• New markets: three verticals established July 2026 — QSEV (EVs), QSDC (AI data centres, led by Shahar Noy, ex-MediaTek/Broadcom/Micron), QSAS (aerospace and defence, led by George Hart).
• Facilities: Eagle Line inaugurated February 2026. An 80,641 sq ft lease was terminated July 2025 with no further obligations; the 61,100 sq ft building at 1762 Automation Parkway was subleased to Momentus Inc. in December 2025 for ~$11.5m of base rent through 2032 — roughly 142,000 sq ft of footprint removed in eighteen months, explicitly “consistent with the Company’s technology licensing focus.”
• Management and board: Dr. Luca Fasoli joined as COO in May 2025 (ex-Western Digital/SanDisk). Geoffrey Ribar (ex-CFO of Cadence Design Systems and NVIDIA) joined the board 2026-01-29. Dr. Ross Niebergall (ex-President, Aerojet Rocketdyne segment of L3Harris; ex-CTO L3Harris/Harris) joined 2026-03-04, three months before the defence vertical was announced. Co-founder Prof. Dr. Fritz Prinz retired from the board on 2026-02-04 after more than fifteen years. Of the three founders, only CTO Dr. Timothy Holme remains in an operating role; founder-CEO Jagdeep Singh handed over to Dr. Siva Sivaram in February 2024 and subsequently retired as Chairman, with Dennis Segers taking the chair on 2025-01-01.
• Listing: transferred voluntarily from the NYSE to Nasdaq, effective 2025-12-23.
• Workforce: 12% reduction in force during 2025, taking headcount to approximately 700 at year-end.

Appendix B — Sources

QuantumScape Corporation (NASDAQ: QS) · CIK 0001811414 · Report date 2026-07-31 All URLs accessed 2026-07-31 unless otherwise noted. Every EDGAR URL below was taken directly from the SEC filing index and HTTP-verified before publication. Primary sources are listed first.

B.1 Primary — SEC filings (the trailing 60-month corpus)

The full 60-month corpus (800 filings; 120 primary documents plus 428 Form 4s) was enumerated and mirrored locally. The documents actually relied upon:

Annual reports (Form 10-K)

Principal reliance: FY2025 10-K Item 1 (Business — technology, separator, QSE-5, PowerCo collaboration and IP Licence terms, 400+ patents, ~700 employees, 12% reduction in force); Item 1A (Risk Factors — perpetual licence language, jointly-owned foreground IP, milestone/licensing risk); Item 3 and Note 7 (legal proceedings); Item 7 MD&A (results of operations, liquidity, ATM history); Item 8 (financial statements). Cover page confirms Nasdaq listing and well-known-seasoned-issuer status.

Quarterly reports (Form 10-Q)

Principal reliance (Q2 2026 10-Q): condensed consolidated balance sheet, statements of operations, stockholders’ equity and cash flows; Note 1 (“Planned principal operations have not yet commenced”); Note 9 (antidilutive securities: 3.2m options, 31.6m RSUs, 12.8m PSUs); Note 10 (Related Party Transactions — the ASC 730-20 / ASC 470-50 treatment of the $10.353m PowerCo receipt as a capital contribution to APIC); Note 11 (Subsequent Events — the $75.4m PowerCo maximum); MD&A (results, PowerCo history, “Access to Capital,” $859.0m liquidity).

Current reports (Form 8-K) — the material-event timeline

Shareholder letters (Exhibit 99.1 to the earnings 8-Ks)

The earnings 8-K primary document is a cover page only; the substance is in Exhibit 99.1, which was fetched separately.

Source of: the “customer billings” definition and quarterly figures; Adjusted EBITDA reconciliation and FY2026 guidance ($250–275m loss); capex guidance and its two revisions; the $859.0m liquidity figure; the Eagle Line >90% uptime and H2 output-doubling statements; the three-vertical announcement (QSEV/QSDC/QSAS); the Murata and Corning ecosystem references; the Honda partnership framing; and the Q3 2025 disclosure that the ATM was completed “before our shelf registration statement expired on August 10.”

Proxy statement

• DEF 14A filed 2026-04-23 — https://www.sec.gov/Archives/edgar/data/1811414/000119312526173828/qs-20260423.htm Source of: the Summary Compensation Table (CEO $8,377,033 in 2025; $19,606,478 in 2024; ~$24.8m aggregate for five NEOs); the 2025 Bonus Plan 100%-of-target payout; PSU vesting outcomes; the April 2026 refresh-grant structure including relative TSR; clawback, anti-hedging/anti-pledging and double-trigger provisions; the EPA Program sunset; Compensia’s role as compensation consultant; and the beneficial-ownership table (Volkswagen 26.2% of vote; directors and officers 51.3% of Class B / 20.5% of vote; Holme 11.0%; Prinz 9.1%).
• DEF 14A filed 2025-04-24 — https://www.sec.gov/Archives/edgar/data/1811414/000095017025058125/qs-20250424.htm

Registration statements and listing documents

• Form S-3 filed 2022-07-29 — https://www.sec.gov/Archives/edgar/data/1811414/000119312522206707/d272054ds3.htm (the last shelf; expired 2025-08-10)
• Form 424B5 filed 2023-08-04 — https://www.sec.gov/Archives/edgar/data/1811414/000119312523203852/d535217d424b5.htm (the last prospectus supplement)
• Form 25 filed 2025-12-22 (NYSE delisting) — https://www.sec.gov/Archives/edgar/data/1811414/000119312525328830/d75353d25.htm
• Form 8-A12B filed 2025-12-22 (Nasdaq registration) — https://www.sec.gov/Archives/edgar/data/1811414/000119312525328821/d69947d8a12b.htm

Insider filings (Forms 3, 4, 5)

All 428 Form 4 filings in the 60-month window were enumerated from the EDGAR filing index, and every accession’s underlying XML was retrieved and parsed directly (<transactionCode>, <transactionDate>, <transactionShares>, <transactionPricePerShare>, <reportingOwnerRelationship>). The census is complete: 428 of 428 accessions parsed. Individual accessions are not listed here; the corpus root is: https://www.sec.gov/Archives/edgar/data/1811414/<accession>/ (template, not a live link) Source of: the zero open-market-purchase (code P) finding, the $368.5m aggregate insider-sales figure and weighted-average price of $12.45, the per-officer detail, the calendar-year sales profile, and the October 2025 eight-insider selling cluster. Retrieval required rate-limited serial requests; an initial parallel fetch triggered SEC HTTP 429 responses.

XBRL structured data

• EDGAR XBRL companyfacts — https://data.sec.gov/api/xbrl/companyfacts/CIK0001811414.json Source of every multi-year financial series in the Financial Quality and Capital Allocation sections (R&D, G&A, operating loss, net loss, share-based compensation, operating/investing/financing cash flow, capex, cash, marketable securities, assets, liabilities, equity, PP&E, weighted-average shares). All figures were cross-checked against the corresponding filed statement.

B.2 Primary — market and quantitative data

• AZI Trading price history (OHLCV, split- and dividend-adjusted) — https://azitrading.com/controls/download-data.php?t=QS 1,495 daily observations from 2020-08-17 to 2026-07-30. Source of: the all-time high ($132.73, 2020-12-22), all-time low ($3.40, 2025-04-08), 2025 high ($19.07, 2025-10-15), 52-week range, EMA configuration (50-day $6.73 vs 200-day $8.01; 110 consecutive sessions of bearish crossover since 2026-02-23; 38 consecutive closes below the 200-day), the largest daily moves used in the five-year event map, and 90-day average volume (23.8m shares, ~$170m/day).
• AZI Trading valuation_index — own-history valuation percentile ranks. Returned n_components = 1: P/B 2.8798 at the 44.6th percentile on a (stale, Q1) book value per share of $1.8161; P/E and P/S percentiles null.
• FactorsToday factor model — https://www.factorstoday.com/api
  • /api/stock-loadings/QS — factor betas across four nested models (Base R² 29.7%; Base+Sector 29.0%; Base+Sector+Industry 30.4%; All Factors 30.0%).
  • /api/leaderboard/QS — annualised risk-adjusted track record: y5 return −25.3%, volatility 86.4%, max drawdown −91.4%, Sharpe −0.32, Sortino −0.59; y1 −40.4%, Sharpe −0.49; m6 −71.8%, m3 −73.5% (annualised).
  • /api/stock-info/QS — beta 2.06, alpha −0.54, rs_ytd −49.8%, rs_peak −96.0%. (Note: market capitalisation reported here counts Class A only.)
  • /api/stock-specific-vol/QS — idiosyncratic volatility 74.9% annualised.
  • /api/related-stocks/QS — factor-similar peers (PBW 0.981, OUST 0.967, AEHR 0.960, LCID 0.947, EVGO 0.918). Methodology: https://www.factorstoday.com/about
• ROIC.ai MCP — get_company_news (news sweep, 2026-01-01 to 2026-07-31) and get_enterprise_value (used as a cross-check only; its Q1 2026 EV of $3,088.9m omits $759.6m of marketable securities and its Q2 2026 record has null cash/debt fields, so enterprise value was rebuilt by hand from the filed balance sheet).

B.3 Primary — counterparty and partner disclosure

• Volkswagen Group press release, “PowerCo confirms results: QuantumScape’s solid-state cell passes first endurance test” (January 2024) — https://www.volkswagen-group.com/en/press-releases/powerco-confirms-results-quantumscapes-solid-state-cell-passes-first-endurance-test-18031 The single external validation in the public record: a 24-layer A-sample cell completed >1,000 charge cycles retaining >95% capacity, against an industry-standard target for that development phase of 700 cycles and up to 20% capacity loss, and met fast-charge, safety and self-discharge criteria.
• QuantumScape investor relations — https://ir.quantumscape.com/ (press releases, including “QuantumScape Announces Shipment of B1 Samples, Achieving a Key Annual Goal,” October 2025).
• QuantumScape press release, “QuantumScape Announces Agreement with Honda on Solid-State Battery Technology” (2026-06-18) — https://www.globenewswire.com/news-release/2026/06/18/3314229/0/en/quantumscape-announces-agreement-with-honda-on-solid-state-battery-technology.html
• QuantumScape press release, “QuantumScape Reports Second Quarter 2026 Business and Financial Results” (2026-07-22) — https://www.globenewswire.com/news-release/2026/07/22/3331729/0/en/QuantumScape-Reports-Second-Quarter-2026-Business-and-Financial-Results.html

B.4 Industry and market data

• BloombergNEF, “Lithium-Ion Battery Pack Prices Fall to $108 Per Kilowatt-Hour, Despite Rising Metal Prices” (December 2025) — https://about.bnef.com/insights/clean-transport/lithium-ion-battery-pack-prices-fall-to-108-per-kilowatt-hour-despite-rising-metal-prices-bloombergnef/ Source of: $108/kWh global average pack price (−8% y/y), $105/kWh 2026 forecast, $84/kWh China, LFP cell $36/kWh and LFP pack $50/kWh, and the attribution to Chinese overcapacity and the LFP mix shift.
• U.S. Energy Information Administration, “Hybrid sales rise while battery electric sales remain lower after tax credit expiration” — https://www.eia.gov/todayinenergy/detail.php?id=67885 Source of: US BEV share 6% in H1 2026 vs 7% prior year; record 12% BEV share in September 2025 immediately before the credit expired; record 16% hybrid share in Q2 2026; luxury BEV share 22% → 14%.
• IDTechEx, “Solid-State Battery Commercialization: Mass Production Taking Off” — https://www.idtechex.com/en/research-article/solid-state-battery-commercialization-mass-production-taking-off/32942
• Interact Analysis, “When Will Solid-State Batteries Enter Commercial Production?” — https://interactanalysis.com/insight/when-will-solid-state-batteries-enter-commercial-production/ Together the source of the competitor-timing table: Toyota ~2027–28 (Idemitsu electrolyte pilot plant groundbreaking 2026-01-29, completion targeted end-2027); Samsung SDI ~2027 limited production; CATL semi-solid 2026 / solid-state ~2027–2030; industry consensus of mainstream mass production clustered ~2030+.

B.5 Competitor filings and disclosure

• Solid Power, Inc. (NASDAQ: SLDP) — Q1 2026 results (2026-05-05) and FY2025 results, via company IR and Business Wire: https://www.businesswire.com/news/home/20260505214730/en/Solid-Power-Reports-First-Quarter-2026-Results and https://www.solidpowerbattery.com/investor-relations/investor-news/news-details/2026/Solid-Power-Reports-Full-Year-2025-Results/default.aspx Source of: FY2025 revenue $21.7m; Q1 2026 revenue and grant income $3.1m; liquidity $435.3m (including $121.3m of net proceeds from a January direct offering); 2026 cash-investment guidance $85–100m; the BMW i7 test vehicle; and the SK On pilot-line installation and sulphide-electrolyte line commissioning targeted for end-2026.
• SES AI Corporation (NYSE: SES) — MIT Technology Review, “Why this battery company is pivoting to AI” (2026-03-25) — https://www.technologyreview.com/2026/03/25/1134657/battery-company-ai-pivot-ses/ ; and the company’s reaffirmed FY2026 revenue guidance of $30–35m.
• Peer market data (Amprius AMPX, Enovix ENVX) via FactorsToday /api/stock-info/, 2026-07-30 closes.

B.6 Analytical frameworks

The competitive-advantage and capital-cycle analysis in this article draws on two standard frameworks:

• Bruce Greenwald & Judd Kahn, Competition Demystified — barriers to entry as the dominant question; the three genuine advantage types (supply/cost, demand/captivity, economies-of-scale-plus-captivity); the market-share-stability and ROIC-above-WACC tests. Applied throughout the Competitive Position section.
• Edward Chancellor (ed.), Capital Returns (Marathon Asset Management) — supply-side capital-cycle analysis; the asset-growth anomaly; high returns attracting capital and mean-reverting. Applied in the industry capital-cycle discussion.

B.7 Sources deliberately excluded

Third-party price targets, analyst ratings and rating changes encountered during the news sweep — including Seeking Alpha upgrade/downgrade notes and a published “$7.41–$8.20 target price range” — were excluded from the analysis and appear nowhere in this report. They are not evidence, and no external target has been allowed to become, or to influence, the view expressed here. Retail-oriented commentary (Motley Fool, Benzinga, 247wallst, Zacks, Invezz, MarketBeat) was used only as a triage layer to locate material events and to date price moves; every material claim so identified was verified against the underlying filing or company release before being relied upon.

Note on a recurring third-party data error: several 2026 news wires — including Benzinga, 247wallst and Barron’s within the same week — continue to identify the company as “NYSE: QS.” QuantumScape has traded on Nasdaq since 2025-12-23 (Form 25 and Form 8-A12B filed 2025-12-22). The exchange qualifier has been corrected throughout this report.

B.8 Note on method

Every figure in this article was reconciled to a filed document. The multi-year financial series were pulled from the SEC’s XBRL companyfacts dataset for CIK 0001811414 and cross-checked line by line against the corresponding 10-K or 10-Q. The full trailing-60-month SEC corpus (800 filings) was enumerated from the EDGAR filing index; all 428 Form 4 filings were retrieved and their raw XML parsed directly, which is the basis for the insider-transaction census. Enterprise value and book value per share were rebuilt by hand from the filed balance sheet rather than taken from any data vendor, for the reasons given in the valuation section.